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Abstract
Genes work in a coordinated fashion to perform complex functions. Dis-
ruption of gene regulatory programs can result in disease, highlighting the
importance of understanding them. We can leverage large-scale DNA and
RNA sequencing data to decipher gene regulatory relationships in humans.
In this thesis, we present three projects on regulation of gene expression by
other genes and by genetic variants using two computational frameworks:
co-expression networks and expression quantitative trait loci (eQTL).
First, we investigate the effect of alignment errors in RNA sequencing
on detecting trans-eQTLs and co-expression of genes. We demonstrate that
misalignment due to sequence similarity between genes may result in over
75% false positives in a standard trans-eQTL analysis. It produces a higher
than background fraction of potential false positives in a conventional co-
expression study too. These false-positive associations are likely to mislead-
ingly replicate between studies. We present a metric, cross-mappability, to
detect and avoid such false positives.
Next, we focus on joint regulation of transcription and splicing in hu-
mans. We present a framework called transcriptome-wide networks (TWNs) for
combining total expression of genes and relative isoform levels into a single
ii
sparse network, capturing the interplay between the regulation of splicing and
transcription. We build TWNs for 16 human tissues and show that the hubs
with multiple isoform neighbors in these networks are candidate alternative
splicing regulators. Then, we study the tissue-specificity of network edges.
Using these networks, we detect 20 genetic variants with distant regulatory
impacts.
Finally, we present a novel network inference method, SPICE, to study the
regulation of transcription. Using maximum spanning trees, SPICE prioritizes
potential direct regulatory relationships between genes. We also formulate a
comprehensive set of metrics using biological data to establish a standard to
evaluate biological networks. According to most of these metrics, SPICE per-
forms better than current popular network inference methods when applied
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We can view biology, the science of life and living organisms, as the study
of interconnections within and across multiple layers: from atoms to cells to
tissues to organisms (Craig et al., 2014). Each layer performs certain func-
tions in coordination with other layers. It is necessary to store and transport
information for such coordinated, often complex, tasks. Primarily, cells in a
living organism use DNA (deoxyribonucleic acid) for long-term information
storage and RNA (ribonucleic acid) for information transport. According to
the central dogma of life, DNA is first transcribed into RNA which in turn is
translated into protein. Segments of DNA that code for RNA or protein are
called genes. The process to synthesize RNA or protein from a gene is called
gene expression. Disruption of gene regulatory programs often results in critical
diseases (Lee & Young, 2013), highlighting the importance of understanding
them.
Laboratory experiments traditionally have been the dominating factor
in understanding biology, successfully elucidating fundamental molecular
principles for centuries. Each experiment generally produces some data which
1
is analyzed by humans to gather support for or against a hypothesis. With
the advent of recent technologies, the dimension of certain types of biological
data has become so big that scientists can no longer analyze them manually.
Consequently, large scale computational and statistical methods are becoming
increasingly popular day by day (Biotechnology, 2016). These methods not
only increase the computational power, but also widen the hypothesis space.
By appropriate modelling, we may even answer questions for which the
experiments were not initially designed. Perhaps more importantly, we can
attempt to test a hypothesis where a proper experiment cannot be performed
due to ethical, economical or other reasons. For example, while we may not
perform a gene knockout experiment in humans to test the function of a gene
due to ethical reasons, we can apply computational methods to predict the
function.
Once we know about gene functions and their regulatory mechanisms, we
can utilize the knowledge to diagnose, prevent, and treat diseases. Recent
biotechnological advancements are revolutionizing medical sciences through
vaccine design, drug development, gene therapy, personalize medicine, and
other areas. In fact, more than 250 genomic biomarker-based drugs have
already been approved by the U.S. Food and Drug Administration (FDA) (U.S.
Food and Drug Administration, 2020).
In this thesis, we focus on computational methods to study gene regulation
in humans. Using DNA and RNA sequencing data, we focus on how the
expression of a gene is regulated by either other genes or genetic variants. We




Before diving into the thesis, we provide a brief overview of a few basic
concepts in molecular biology that form the basis of the thesis. For simplicity,
we focus only on typical scenarios in humans. But, please be aware that there
might be exceptions.
1.1.1 Cells and chromosomes
The cell is the structural and functional unit of all living organisms. A typical
human adult has about 37.2 trillion cells (Bianconi et al., 2013). There is a
nucleus in each human cell. The nucleus contains all the chromosomes. Each
chromosome – a threadlike structure of nucleic acids and protein – is actually
a tightly-packaged DNA molecule that carries genetic information of the
organism (see Figure 1.1). Humans have 23 pairs of chromosomes: 22 pairs
of autosomes (chr1, chr2, chr3, . . . , chr22) and one pair of sex chromosomes
(chrX and chrY).
1.1.2 DNA
DNA (deoxyribonucleic acid) molecules carry the hereditary blueprint of
humans and most other organisms. A DNA molecule is composed of two
polynucleotide strands each coiled around the same axis to form a double-helix
structure (Watson & Crick, 1953). Each strand is a long chain of nucleotides,
3
Figure 1.1: Basic concepts of molecular biology. Chromosomes are located in the
nucleus of a cell. Each chromosome, essentially a DNA molecule, consists of two
polynucleotide chains forming a double helix structure. Two strands are connected
by A-T and G-C base pairs. A segment of a DNA codes for a gene. Note: This figure
has been derived from a Wikimedia file available in the public domain.
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each of which has one of the four types of nucleobases, or simply bases: ade-
nine (A), cytosine (C), thymine (T), and guanine (G). It is the sequence of these
four bases that encodes the genetic information and controls the function of
the cells. Notably, adenine (A) in one strand binds with thymine (T) in the
other strand forming an A-T base pair. Similarly, cytosine (C) binds with gua-
nine (G) forming a C-G base pair. Thus, the double-stranded DNA molecule
is a long chain of base pairs. As one base determines the other base in a base
pair, we can represent the DNA as string of A’s, C’s, T’s, and G’s – a chain of
bases. Human genome – the complete genetic code – consists of two copies of
DNA molecules from 23 different chromosomes, each copy having a total of
over 3 billion base pairs (Ensembl Genome Browser 102, 2020).
1.1.3 Genetic variants
About 99.9% of the 3 billion base pairs of the genome are identical between
two human beings. Genetic variation in the rest 0.1% of the genome has the
potential to explain inter-individual differences. For example, people with
certain variations nearby the MC1R gene on chr16 are likely to have red hair
(Valverde et al., 1995). Mutation (variation) at a certain genomic position
may provide us a clue about an individual’s predisposition to a disease. The
mutation where a single nucleotide is substituted with another nucleotide is
called a single nucleotide variant (SNV). If the SNV is detected in a sufficiently
large fraction (e.g., at least 1%) of a population, it is called a single nucleotide
polymorphism (SNP). Mutations other than single nucleotide substitution lead
to other types of genetic variations e.g., an insertion or deletion of bases (also
5
Figure 1.2: The central dogma of molecular biology. DNA is transcribed to RNA
which is then translated to protein. Note: this figure has been derived from a Wikime-
dia file available under CC BY 4.0 license.
known as indels), duplication of bases, inversion of a DNA segment, copy-
number variation, translocation, etc. SNPs and indels are the most common
types of variants in humans. Different forms of a variant (e.g., normal and
mutant) are referred to as alleles.
1.1.4 The central dogma of molecular biology
The central dogma of molecular biology explains how genetic information in
DNA flows in organisms. A segment of a DNA that contains the instructions
for a specific molecule, either ribonucleic acid (RNA) or protein, is called a
gene (see Figure 1.1). According to the central dogma of molecular biology,
the double-stranded DNA of a gene is used as a template to create a single-
stranded messenger RNA (mRNA). Like DNA, an RNA molecule also has
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4 types of bases: adenine (A), cytosine (C), uracil (U), and guanine (G). A
thymine (T) in DNA is replaced by an uracil (U) in RNA. The process of cre-
ating an RNA molecule from a DNA molecule is called transcription. mRNA
created from transcription moves from the nucleus to the cytoplasm. There,
ribosomes read three RNA bases at a time (codon) to produce protein. The
process of creating a protein molecule from an RNA is called translation. Pro-
teins are generally considered as the workhorse of life determining downstream
phenotypes.
The process of producing RNA or protein from a gene is called gene expres-
sion. Transcription and translation determine gene expression i.e. the amount
of RNA or proteins produced from a gene. Because of these processes, even
though the genetic information in DNA is largely same in every cell of an
individual, different tissues or cell types can perform distinct functions.
Humans have about 20,000 protein-coding genes. Notably, not all genes
code for proteins. Genes that do not code for proteins are called noncoding
genes. RNAs produced from these genes are called noncoding RNAs. Ex-
amples include transfer RNA (tRNA), ribosomal RNA (rRNA), small nuclear
RNA (snRNA), micro RNA (miRNA), long noncoding RNA (lncRNA), etc.
There are thousands of noncoding genes in humans. They participate in many
cellular processes including RNA splicing.
1.1.5 RNA Splicing
The single-stranded RNA synthesized from the DNA template of a gene is
called a pre-mRNA (pre messenger RNA). In eukaryotes, including humans,
7
Figure 1.3: RNA Splicing. A) RNA splicing produces mature mRNA from a pre-
mRNA. snRNPs and other proteins bind to pre-mRNA to form a spliceosome. Spliceo-
some brings two ends of an intron together to make a loop. Finally, the intron loop is
excised and the neighboring exons are joined together to form a mature mRNA. B)
Alternative splicing produces different isoforms from the same pre-mRNA produced
by transcription. In this example, each of the three isoforms is translated to a different
protein. Note: Figure B has been derived from a Wikimedia file available in the public
domain.
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pre-mRNAs may be further processed in several steps including polyadeny-
lation, capping, and splicing. RNA splicing is an important process where
some segments of pre-mRNA, called introns, are removed and the remaining
segments, called exons, are joined together to form a mature mRNA or simply
mRNA. During this process, a number of small ribonucleoproteins or snRNPs
(RNA-protein complex) and other proteins form a spliceosome that brings two
ends of an intron together making a loop. The intron loop along with snRNPs
detaches, and the ends of neighboring exons join together (see Figure 1.3A).
In alternative splicing, exons of the pre-mRNA are connected in different
ways to produce different mature mRNAs or isoforms (see Figure 1.3B). Due
to the difference in the sequence, each isoform may produce a different pro-
tein. Thus, alternative splicing enables producing multiple proteins from the
same gene. Each protein isoform may have a different function, therefore,
alternative splicing has the potential to control the downstream phenotype. In
fact, alternative splicing events are up to 30% more common in tumors than
normal samples (Kahles et al., 2018).
1.1.6 Regulation of gene expression
Genes encode the instructions to produce proteins and proteins perform cell
functions. The type and the amount of proteins present in a cell critically
defines the function of the cell and consequently the function of an organism.
Disruption of this delicate balance of the type and the amount of proteins











Figure 1.4: Schematic of transcription. Transcription factors bind to the promoter
region to recruit RNA polymerase II that starts transcription. Activators/Repressors
and genetic variants may control the transcription process.
crucial to understand how this balance is maintained or disrupted in dis-
ease. Importantly, gene expression regulation is affected by both genetic and
environmental factors.
Transcription is a fundamental way to control gene expression. Transcrip-
tion factors (TFs) play an important role in the transcription of a gene. TFs bind
to the promoter region nearby the transcription start site (TSS) of a gene to
recruit RNA polymerase II which transcribes the gene (see Figure 1.4). Binding
of activators in the enhancer regions (relatively distant from the TSS) may
increase the likelihood of transcription. Binding of repressors to the DNA may
prevent transcription. Thus, the transcription of a gene can be modulated by
any genes affecting the transcription machinery. Notably, the transcription
machinery can also be affected by presence or absence of genetic variants. For
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example, the presence of a certain variant may disrupt the transcription factor
binding site and consequently prevent transcription.
Splicing is another major contributor to control gene expression. The
splicosome is dynamically comprised of hundreds of proteins. Splicing regu-
latory elements recruit sequence-specific RNA-binding protein factors, known
as splicing factors, that either activate or repress splice site recognition or
spliceosome assembly.
Gene expression could also be regulated epigenetically by controlling
access to the transcription machinery. DNA methylation and histone mod-
ifications are some of the common ways to regulate DNA accessibility and
chromatin structure.
1.1.7 DNA and RNA sequencing
DNA sequencing is the process of determining the correct order of nucleic
acids in DNA. Though the first genome was sequenced in the 1970s, genome se-
quencing became cost-effective relatively recently because of high-throughput
next-generation sequencing (NGS). NGS breaks up the DNA randomly into
a large number of small fragments, sequences them in parallel, and finally
stitches the small sequences together using computational algorithms to re-
construct the original genome (Langmead & Salzberg, 2012; Langmead et al.,
2009; Li & Durbin, 2009).
NGS can sequence RNAs as well by reverse-transcribing RNAs to com-
plementary DNAs (cDNAs) followed by sequencing (Figure 1.5). Given NGS
11
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Figure 1.5: Schematic of sequence alignment and expression quantification in
RNA sequencing. After collection and preparation of RNA samples, reverse tran-
scription produces cDNA. Fragmentation of cDNA followed by sequencing produces
short reads. Short reads are aligned to the reference genome and expression is quanti-
fied.
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sequences only short reads, two steps are critical in RNA sequencing (RNA-
seq): sequence alignment and expression quantification. During sequence
alignment, each read is mapped (or aligned) to a reference genome to deter-
mine which genomic region was transcribed to form the corresponding RNA.
Sequence alignment algorithms look for the degree of similarity between each
read and the reference genome to find the correct region. Splicing-aware
aligners are good candidates for aligning RNA-seq reads (Dobin et al., 2013;
Kim et al., 2015; Kim et al., 2019; Kim et al., 2013; Trapnell et al., 2009).
Expression quantification is the process to estimate the abundance of reads
aligned to each gene, isoform, exon, or other levels. While the simplest
approach is to count the number of reads aligned to a genomic region, special
attention may be required to disambiguate overlapped regions (Anders &
Huber, 2010; Kovaka et al., 2019; Li & Dewey, 2011; Love et al., 2014; Patro
et al., 2017; Pertea et al., 2015). Notably, some software tools can quantify
expression without alignment making the process fast (Bray et al., 2016; Patro
et al., 2017).
Recent technologies can sequence long reads though the error rate is
slightly higher than short reads (Chin et al., 2013; Greninger et al., 2015).
Currently, single-cell sequencing is gaining popularity (Macosko et al., 2015;
Picelli et al., 2014; Xia et al., 2019; Zheng et al., 2017).
1.2 Computational frameworks
In this thesis, we use DNA and RNA sequencing data to decipher gene regula-
tory programs in humans. We study how expression of a gene is regulated by
13
Figure 1.6: Gene co-expression network (GCN). Each node represents a gene and
each edge connecting two nodes represents co-expressed gene pairs. The width of
each edge is proportional to their co-expression.
other genes and genetic variants following two computational frameworks,
co-expression networks and quantitative trait loci (QTL), respectively.
1.2.1 Co-expression networks
A gene co-expression network (GCN) is schematically represented by an
undirected graph where each node represents a gene and a pair of nodes are
connected by an edge if they are significantly co-expressed (Stuart et al., 2003)
(Figure 1.6). Each edge may have a weight, giving rise to a weighted gene co-
expression network, where the weight represents the strength of co-expression.
A weight of zero means that the nodes are not co-expressed. Connected genes
generally have similar functions or they are involved in a common biological
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process.
The structure of a gene co-expression network is an abstraction of the
molecular dynamics in a particular context. It represents biological pathways –
the cascading of information flow in a biological system. A gene co-expression
network can help us understand biological processes. Applied in a disease
context, it can help us discover disease mechanisms and find appropriate drug
targets (Mei et al., 2012; Saha et al., 2015; Saha et al., 2014).
WGCNA, Weighted Gene Co-expression Network Analysis (Langfelder &
Horvath, 2008; Zhang & Horvath, 2005), is one of the simplest and most popu-
lar methods to infer a co-expression network from gene expression data. It
estimates the edge weight (Wij) between a pair of genes as their co-expression
similarity raised to a power β.
Wij = cor(xi, xj)β (1.1)
Here, xi and xj represent expressions of gene i and gene j, respectively, and
β ≥ 1 is selected in such a way that the network follows a scale-free topology.
Though simple in nature, WGCNA successfully found modules in many
different contexts (DiLeo et al., 2011; Hartl et al., 2020; Yin et al., 2018; Zhai
et al., 2017). A limitation of WGCNA is that it cannot distinguish between
direct edges and indirect edges via other genes.
Graphical lasso (Friedman et al., 2008), another popular network inference
method, attempts to learn potentially direct edges between genes by learning
a precision matrix (also known as an inverse covariance matrix, Θ̂) with L-1
15
Variant
















Figure 1.7: Expression quantitative trait loci (eQTL). A) A variant on the x-axis
explains the expression of a gene on the y-axis to form an eQTL (variant-gene pair).




− log det Θ + tr(SΘ) + λ∥Θ∥1 (1.2)
Here, S is the sample covariance matrix and λ is the penalty parameter. A nice
property of the precision matrix is that a non-zero value represents conditional
dependency between the corresponding genes given other genes. However,
graphical lasso is very slow for a high number of genes, and often the selection
of an optimal lambda using cross-validation is practically infeasible.
Examples of other popular co-expression network inference methods in-
clude ARACNE (Margolin et al., 2006), CLR (Faith et al., 2007), MRNET
(Meyer et al., 2007), MRNETB (Meyer et al., 2010), and GENIE3 (Huynh-Thu
et al., 2010).
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1.2.2 Quantitative trait loci (QTLs)
A quantitative trait loci (QTL) study finds genetic variants explaining the
variation in a quantitative trait (Nica & Dermitzakis, 2013). When the trait
is the expression of a gene, it is called an expression quantitative trait loci
(eQTL) study. Figure 1.7A illustrates that the variant on the x-axis determines
the level of expression of a gene on the y-axis. Formally, we test for a linear
association between gene expression y and genotype x.
y = α + βx + ϵ, where ϵ ∼ N (0, σ2) (1.3)
When x and y are significantly associated (β ̸= 0), we call the variant-gene
pair an expression quantitative trait locus (eQTL). The variant and the gene are
referred as an eVariant and an eGene, respectively. β is generally referred as
the effect size.
There are two types of eQTLs: cis and trans. A cis-eQTL acts on the
same DNA molecule, and a trans-eQTL acts on a different molecule. We
approximate cis and trans-eQTLs based on the distance between the variant
and the gene. If the variant resides nearby the gene, typically within 1 Mb
of the gene’s transcription start site (TSS), the variant-gene pair is called a
cis-eQTL (Figure 1.7B). In contrast, if the variant resides away from the gene,
typically on a different chromosome, the variant-gene pair is called a trans-
eQTL. Finding trans-eQTLs is more challenging than cis-eQTLs because of the
high number of tests and relatively small effect sizes. Any technical bias can
further complicate the problem. We focus on trans-eQTLs in this thesis.
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In both cis- and trans-eQTLs, the variant likely regulates the expression
of the gene, or the variant is in linkage disequilibrium (LD) with the variant
regulating the gene. EQTLs provide a mechanism to explain how a genetic
variant may control a downstream phenotype through regulating intermediate
molecular phenotypes such as gene expressions (Dutta et al., 2020; Gill et al.,
2020; Hawe et al., 2020; The GTEx Consortium, 2017, 2020; Võsa et al., 2018).
1.3 Challenges
A common challenge in computation genomics is the limited number of
samples. While we can quantify more than 20,000 genes with the advent of
recent sequencing technologies, the number of samples is still in the range of
hundreds for a specific tissue or study. The challenge gets further complicated
for co-expression networks and trans-eQTLs because of millions of parameters
estimation in co-expression networks and billions of tests in trans-eQTLs.
Any systematic error in sequencing experiments, sequencing alignment,
expression quantification, or any other data processing pipeline may produce
spurious associations in the data affecting both co-expression networks and
trans-QTL studies. If not properly handled, batch effects and unmeasured
technical factors may confound both types of studies. Even random white
noise in data could be critical because of the relatively small sample size
compared to the number of tests.
A big challenge in a co-expression network estimation is to distinguish
between direct and indirect edges. The presence of collinear genes makes
the challenge harder. Complex models easily overfit the data because of a
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relatively small number of samples. Advanced models might be prohibitively
slow to run. Besides, appropriate biological ground truths generally do not
exist, making the network evaluation difficult.
A trans-eQTL analysis takes a long time and memory to run. It also takes a
large amount of disk space to save the eQTL statistics. Besides, multiple testing
correction is tricky for a trans-eQTL analysis because of linkage disequilibrium
between genetic variants.
1.4 Thesis outline
We address some of the above challenges in the remaining chapters.
• In Chapter 2, we investigate a potential source of technical errors in
trans-eQTL and co-expression network studies. We study the prevalence
of such technical errors in a standard pipeline using human data. We
also present an approach to detect and avoid potential false positives
due to these errors. This chapter is based on a published work from
Saha and Battle, 2018.
• In Chapter 3, we turn to a network system to jointly study the regulation
of transcription and alternative splicing. By appropriate modeling of
RNA-sequencing data, we attempt to find potential splicing regulators
in humans. We further analyze tissue-specificity of transcription and
splicing regulatory relationships and detect genetic variants supporting
these relationships. This chapter is based on a published work from
Saha et al., 2017.
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• In Chapter 4, we present a novel network inference method named
SPICE to prioritize potential direct regulatory relationships in transcrip-
tion. We also present a comprehensive set of metrics to evaluate net-
works using biological data.
• Finally, in Chapter 5, we conclude the thesis by summarizing the findings




in trans-eQTL and co-expression
studies
Expression quantitative trait loci (eQTL) and co-expression networks, as we
described in Chapter 1, are two effective and popular tools to study gene
regulation. These methods generally make a large number of tests and/or
estimate a large number of parameters using a limited number of data samples.
Consequently, these methods have limited power to detect true regulatory
relationships. Any systematic error in the pipeline from sample collection
to statistical analysis, if not handled properly, can result into false positive
discoveries. It is critical to detect the sources of false discoveries and take
necessary steps to avoid related consequences. In this work, led by me, we
assessed the potential for incorrect alignment of RNA-sequencing reads to
cause false positives in both gene expression quantitative trait loci (eQTL) and
co-expression analyses. Our main contributions are as follows:
• Trans-eQTLs identified from human RNA-sequencing studies appeared
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to be particularly affected by alignment errors due to sequence similar-
ity, even when only uniquely aligned reads are considered. Over 75%
of trans-eQTLs detected using a standard pipeline occurred between
regions of sequence similarity and therefore could be due to alignment
errors.
• Associations due to mapping errors are likely to misleadingly replicate
between studies.
• To help address this problem, we quantified the potential for cross-
mapping to occur between every pair of annotated genes in the human
genome. Such cross-mapping data can be used to filter or flag potential
false positives in both trans-eQTL and co-expression analyses.
This work was published in F1000 Research (Saha & Battle, 2018), and this
chapter is based on the published article.
2.1 Introduction
Sequence similarity among distinct genomic regions makes alignment of short
sequencing reads difficult (Johnson et al., 2016; Kahles et al., 2016). Genomes,
including the human genome, contain diverse classes of elements with se-
quence similarity across regions, ranging from large segmental duplications
to pseudogenes to transposable elements. Alignment-based quantification
of genomic phenotypes such as gene expression or epigenetic signal is less
reliable for such regions (Degner et al., 2009; Derrien et al., 2012; Karimzadeh
et al., 2018; Robert & Watson, 2015).
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Reads mapped where they originated
Reads originated here, but mapped elsewhere
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3. Count the number of k-mers from gene A  whose 
alignments start within exons or UTRs of other genes.
Crossmap: A → B = 2,   Crossmap: A → C = 1




2. Align to the reference genome with mismatches.
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Figure 2.1: Overview of cross-mappability. A) Some of the reads generated from
Gene A are incorrectly mapped to Gene B because of sequence similarity between
the genes, leading to false positive co-expression. Consequently, a variant which is
a true cis-eQTL of Gene A appears as a false positive trans-eQTL of Gene B. B) We
align the ambiguous (orange) k-mers (75-mers from exons and 36-mers from UTRs)
from Gene A to the reference genome using Bowtie and count how many k-mers from
Gene A map to each other gene to compute cross-mappability. Here, the number
beside each ambiguous (orange) k-mer represents the identifier for the ambiguous
k-mer based on its position in Gene A.
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Despite attention to the importance of alignment errors, the full range
of consequences is not always considered in downstream analyses. Here,
we focus on evidence that sequence similarity between pairs of genes and
resulting alignment errors between them may lead to false positives in associa-
tion studies from RNA-sequencing (RNA-seq) data, specifically in expression
quantitative trait locus (eQTL) and co-expression analyses. eQTL studies,
revealing associations between genetic variants and gene expression levels,
have contributed to a greater understanding of gene regulation and genetics
of complex traits (Albert & Kruglyak, 2015; Grundberg et al., 2012; Nica &
Dermitzakis, 2013). Trans-eQTLs, where the genetic variant is distant or on
a different chromosome from the associated gene, are of particular interest,
but have proven challenging to identify in human data due to power, con-
founders, small effect sizes, and other challenges (The GTEx Consortium, 2017;
Westra et al., 2013). Given that a trans-eQTL analysis performs genome-wide
tests, it is more prone to be affected by systematic errors between genomic
regions than a cis-eQTL analysis where only variants close to the target gene
are considered. Here, we discuss the impact of alignment errors on RNA-seq
association studies. Figure 2.1A illustrates a cartoon example, where all reads
truly originate from transcripts of Gene A, but due to sequence similarity
between Gene A and Gene B, some of the reads incorrectly map to Gene B,
causing it to erroneously appear to be expressed in the sample. The number
of reads misaligned to Gene B across samples may be directly proportional to
the number of reads for Gene A, or may be determined by genetic variation
creating sequence mismatches with the correct region. In either case, spurious
associations can then arise. In Figure 2.1A, the two genes incorrectly appear to
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be co-expressed. In addition, a variant associated with expression of Gene A
may also appear to be associated with Gene B, giving rise of a false positive
trans-eQTL. We note that such errors are not entirely mitigated by filtering
multi-mapped reads—some alignment errors may remain between similar
regions even among uniquely aligned reads due to genetic variation, errors in
the reference genome, and other complications.
Previous studies have shown that uniqueness of sequence in genomic
regions should be considered in an analysis of sequencing data (Derrien et al.,
2012; Karimzadeh et al., 2018; van de Geijn et al., 2015). Karimzadeh et al.
showed that a differential methylation analysis can identify false signals due to
poor mappability (Karimzadeh et al., 2018). We have previously filtered trans-
eQTLs based on sequence similarity as part of the Genotype-Tissue Expression
(GTEx) project (The GTEx Consortium, 2017) and the Depression Genes and
Networks (DGN) study (Battle et al., 2014). Pickrell et al. (Pickrell et al., 2010)
also suggested that the most significant distant eQTL in their RNA-seq study
was likely an artifact arising due to sequencing reads originating from a gene
near the SNP mapping to another distant gene. Related effects were also
discussed in greater depth for microarrays, where probes intended for one
gene may cross-hybridize to other genes (Reilly et al., 2006; Westra et al., 2013).
In microarray studies, one could identify and replace probes displaying poor
specificity, but in RNA-seq, any region of sequence similarity between genes
can cause alignment errors. Previous studies have not presented a systematic
analysis of alignment-related false positives in RNA-seq association testing.
Here, we report the prevalence of potential false positives in trans-eQTL
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and co-expression analyses arising from alignment errors. We present a
method to assess the potential for mapping error between pairs of genes,
which can then be used to filter or flag associations that could arise from these
errors. We introduce a new metric, cross-mappability, representing the extent
to which reads from one gene may be mapped to another gene. Using gene
expression data from GTEx (The GTEx Consortium, 2017) and DGN (Battle
et al., 2014), we demonstrate the impact of misalignment on both trans-eQTL
detection and co-expression analysis in real data. Notably, we show that over
75% of trans-eQTLs detected in any GTEx tissue using a naive pipeline are
potential false positives, emphasizing that it is critical to consider these errors.
To support future studies, we have published codes in Github (Saha & Battle,
2019a) and also made cross-mappability resources publicly available for the
human genome (hg19 and GRCh38) (Saha & Battle, 2019b).
2.2 Methods
2.2.1 Mappability and cross-mappability
We developed a new metric, cross-mappability, to quantify the potential for
incorrect read alignment where reads originating from one gene may incor-
rectly map to another gene. Based on annotated transcripts for each gene,
we evaluated k-mers from exonic and untranslated regions (UTRs) of the
reference genome that serve as a proxy for reads in an RNA-seq experiment.
We defined cross-mappability from Gene A to Gene B, crossmap(A, B), as the
number of Gene A’s k-mers whose alignment, allowing mismatches, start
within exonic or untranslated regions of Gene B. Notably, existing mappability
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scores (Derrien et al., 2012; Karimzadeh et al., 2018) correspond to a single
region (or gene) describing uniqueness of the sequence of the region in the
genome, our cross-mappability score corresponds to a pair of genes describing
similarity between the sequences of the genes.
Though cross-mappability is a straightforward metric, its computation is
non-trivial due to the size of the genome. We followed a systematic approach
to compute genome-wide cross-mappabilities in practice. Following Derrien
et al., 2012, we define mappability of a k-mer as 1Ck , where Ck is the number
of positions where the k-mer maps to the genome with a tolerance of up
to 2 mismatches. We computed exon- and UTR-mappability of a gene as
the average mappability of all k-mers in exonic regions and untranslated
regions, respectively. We used a collapsed gene model to generate k-mers
where overlapped exons and overlapped UTRs were merged to form exonic
and UTR regions, respectively. Then, mappability of a gene is computed
as the weighted average of its exon- and UTR-mappability, weights being
proportional to the total length of exonic regions and UTRs, respectively.
Importantly, we only have to compute cross-mappability from genes with
mappability < 1, as no k-mer from a gene with mappability = 1 will map to
other regions of the genome (i.e. these will all result in cross-mappability of
0). Moreover, we need to consider only k-mers with mappability < 1 from
a gene, as uniquely mapped k-mers will not map to other genes. So, we
align all such k-mers from exonic and untranslated regions of each gene to
the reference genome using Bowtie v1.2.2 (Langmead et al., 2009), tolerating

































































































































Figure 2.2: Cross-mappability statistics. Cross-mappability statistics. A) Distribu-
tion of cross-mappability between cross-mappable pairs of genes, restricted to gene
pairs with cross-mappability > 0, using Gencode v19 annotations on human genome
hg19. B) Background percentage of cross-mappable gene pairs between all available
expressed genes in GTEx data, categorized by tissue. For both panels, directed gene
pairs were used; i.e., (Gene A, Gene B) and (Gene B, Gene A) pairs were considered
different.
start within exonic or untranslated regions of every other gene to compute
cross-mappability with each gene genome-wide (Figure 2.1B).
The length k may be tuned to match particular read length or alignment
method. Here, if the value of k is not mentioned for k-mers, the default value
of k is 75 for exons and 36 for UTRs. We used a smaller k for UTRs than for
exons because UTRs are generally shorter than exons. Mappability of a gene
and cross-mappability to/from a gene is undetermined if all the exons of the
gene are shorter than 75 bp and all the UTRs are shorter than 36 bp.
We computed genome-wide mappability and cross-mappability for human
genome hg19 using annotations from Gencode v19 (Harrow et al., 2012).
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26,200 (out of 57,820) genes had at least one k-mer cross-mapping to/from
another gene. There were 31,167,448 gene pairs (0.93%) that were cross-
mappable (cross-mappability > 0). Figure 2.2A shows the cross-mappability
distribution. We found that 2.45-4.92% of gene pairs expressed and quantified
in five tissues of the GTEx v7 data were cross-mappable (Figure 2.2B). We
also computed the same set of resources for human genome GRCh38 using
annotations from Gencode v26, all of which are publicly available (Saha &
Battle, 2019b).
2.2.2 Data
We downloaded fully processed, filtered and normalized gene expression
data used in GTEx eQTL analysis from the GTEx portal (www.gtexportal.org).
For this study, we focused on gene expression data from 5 tissues: whole
blood, skeletal muscle, thyroid, sun-exposed skin, and testis. We also obtained
covariates including 3 genotype PCs representing ancestry, sex, genotyping
platform, and PEER factors (Stegle et al., 2012) as released in GTEx v7. GTEx
aligned 76-bp paired-end reads to the reference genome with STAR v2.4.2a
(Dobin et al., 2013), quantified gene expression levels with RNA-SeQC v1.1.8
(DeLuca et al., 2012) using uniquely mapped reads aligned in proper pairs
and fully contained within exon boundaries where each alignment must not
contain more than six non-reference bases. We downloaded genotype data
from GTEx release v7 from dbGaP (accession number: phs000424.v7.p2).
We also collected genotype, processed RNA-seq, and covariate data for
the DGN cohort, which is available through the National Institute of Mental
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Health (NIMH) Center for Collaborative Genomic Studies on Mental Disor-
ders. DGN aligned the reads to the reference genome using TopHat (Trapnell
et al., 2009) and quantified gene expression levels using HTSeq (Anders et al.,
2015). Latent factors inferred from the expression data have already been
regressed out of the processed DGN data to address hidden confounders, as
described by Battle et al., 2014. Gene symbols were mapped to Ensembl gene
ids using Gencode v19.
We downloaded the list of trans-eQTLs in 33 cancer types detected by Pan-
canQTL (Gong et al., 2018) from http://bioinfo.life.hust.edu.cn/PancanQTL.
For consistency with our study, we used trans-eQTLs where the variant and
the gene were on different chromosomes, and the gene symbols were mapped
to unique Ensembl gene ids according to Gencode v19.
2.2.3 Trans-eQTL detection
For trans-eQTL analysis, we selected autosomal variants with MAF ≥ 0.05
that did not fall in a repeat region as annotated by the UCSC RepeatMasker
track (Casper et al., 2017). We tested trans-eQTL association for each inter-
chromosomal variant-gene pair using Matrix-eQTL’s linear model test (Sha-
balin, 2012). For GTEx, three genotype PCs, genotyping platform, sex, and
PEER covariates estimated by GTEx were used as covariates in Matrix-eQTL.
We computed the false discovery rate using the Benjamini-Hochberg method
within each tissue. The covariates used for trans-eQTL replication in DGN
were three genotype PCs, sex and age, as the expression data already had
latent factors regressed out.
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2.2.4 Co-expression analysis
We quantified co-expression of a pair of genes as the absolute Pearson correla-
tion (|r|) between expression levels of the genes across all available samples.
For GTEx, we regressed out all covariates including PEER factors before co-
expression analysis. For DGN, we used the corrected data which also regresses
out latent factors.
2.3 Results
2.3.1 Effect of cross-mappability on trans-eQTL detection
To investigate the effects of alignment errors on trans-eQTL detection, we
performed a standard trans-eQTL analysis using data from the GTEx project
for five human tissues. For this study, we categorized an eQTL as “cis” if
the variant is within 1Mb of the transcription start site (TSS) of the gene,
and “trans” if they are on different chromosomes, approximating the regions
where cis and trans mechanisms are likely to occur. We call a trans-eQTL
“cross-mappable” if any gene within 1Mb of the identified trans-eQTL variant
cross-maps to the trans-eQTL target gene. The cross-mappable trans-eQTLs
represent suspicious hits that could potentially arise simply due to alignment
errors, although cross-mappability does not definitively establish that any
individual trans-eQTL is a false positive.
We identified 19,348 unique trans-eQTLs (variant-gene pairs) at FDR ≤
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Figure 2.3: Effect of cross-mappability on trans-eQTLs in GTEx. Fraction of cross-
mappable trans-eQTLs among the top significant variant-gene pairs (ordered by
increasing FDR) in each tissue (color). Each dotted horizontal line represents the
background cross-mappable rate in a given tissue.
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Figure 2.4: Cross-mappability in top trans-eQTL hits A) using protein-coding genes
in GTEx, B) using genes with mappability ≥ 0.8 in GTEx, C) using protein-coding
genes with mappability ≥ 0.8 in GTEx, and D) by PancanQTL where unique eQTLs
were ordered by lowest p-value across all cancer types.
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genes. Notably, a large majority (75.14%) of these statistically significant trans-
eQTLs were cross-mappable. Furthermore, the cross-mappable eQTLs tended
to be the most highly significant (ordered by increasing p-value, Figure 2.3).
In GTEx tissues, 90.8-97.3% of top 1000 trans-eQTLs were cross-mappable,
compared to a background rate of 19.1-25.6% (based on all tested variant-gene
pairs). The fraction of cross-mappable trans-eQTLs is very high even when
we restrict our analysis to protein-coding genes or to genes with mappability
≥ 0.8 (Figure 2.4A-C).
We observed a similar pattern in the trans-eQTLs reported from RNA-seq
data of 33 cancer types (Gong et al., 2018) (Figure 2.4D). We also observed that
randomly selected variant-gene pairs susceptible to cross-mapping yield more
trans-eQTLs than randomly selected pairs with no cross-mapping potential
(Figure 2.5). Overall, the high fraction of cross-mappable eQTLs among the top
associations in multiple tissues and multiple datasets indicates that alignment
errors could be a major source of artifacts, dominating legitimate trans-eQTLs.
It is also important to note that filtering such prevalent potential false-positives
necessitates re-assessing FDR. For example, while 4,809 trans-eQTLs with no
evidence of cross-mapping (corresponding to 969 unique genes) were among
the 19,348 hits from the original scan of GTEx, only 2,456 (corresponding
to 228 unique genes) would appear significant if FDR were reassessed after
filtering cross-mapping hits.
When we further analyzed the composition of the 19,348 significant naive
trans-eQTLs, we observed a majority (>70%) of cross-mappable eQTLs corre-
sponded to pseudogene targets. The non-cross-mappable eQTLs contained far
34
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Testis
Figure 2.5: Large number of trans-eQTLs among random cross-mappable gene
pairs. We tested for trans-eQTLs taking the same number of random variant-gene
pairs in 3 different categories: 1) Not cross-mappable, 2) Cross-mappable, and 3)
Cross-mappable (Top). In the first category, we randomly selected 1,000 not cross-
mappable gene pairs (g1, g2) where g1 and g2 were on different chromosome and
there was at least one variant near g1 (within 1Mb of the TSS of g1), then selected the
best cis-variant s (with lowest p-value) for g1, and finally tested for trans-association
between s and g2. Variant-gene pairs for other two categories were selected in a
similar way as the first category except that the gene pairs were cross-mappable
(crossmap(g1, g2) > 0) in the second category, and highly cross-mappable (among top
10,000 cross-mappable pairs) in the third category. The above plot shows the number
of significant trans-eQTLs (y-axis) detected at a given FDR (x-axis) in each category










































































































Processed pseudogene Transcribed unprocessed pseudogene
Unprocessed pseudogene Transcribed processed pseudogene
Not annotated
C
Figure 2.6: Composition of trans-eQTLs. A) Representation of gene types among
trans-eQTL target genes, categorized by cross-mappability. B) Proportion of cross-
mappable eQTLs categorized by gene type. Only the four most frequent gene types
in trans-eQTL hits are shown. C) Among trans-eQTLs with a pseudogene target gene,
quantification of different pseudogene sub-types, categorized by cross-mappability.
Pseudogene sub-types were identified from the Gencode v26 annotation, as sub-types
are not available in Gencode v19. The five most frequent types among trans-eQTL
hits are shown.
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fewer pseudogene targets ( 30%, Figure 2.6). Likewise, we observed that more
than 85% of eQTLs corresponding to pseudogenes were cross-mappable. Due
to sequence similarity between pseudogenes and their corresponding parent
genes, this is not surprising and could be due to alignment errors. One simple
preventative measure in trans-eQTL studies would be to simply exclude pseu-
dogenes entirely. However, 42.4% of eQTLs corresponding to protein-coding
genes were also cross-mappable, which still exceeded expectation, and the top
hits remained enriched for cross-mapping errors as noted above.
We investigated one GTEx trans-eQTL in greater detail for illustration –
variant: chr5:149826526 and gene: RP11-343H5.4 (ENSG00000224114) – which
was significant in each of 5 GTEx tissues. RP11-343H5.4 is a pseudogene on
chromosome 1. In the coverage plots of the gene, we noticed that reads were
aligned to only a fraction of the exonic region of the gene; if the gene were
truly expressed, we would expect reads being mapped across the whole exon
(Figure 2.7). RP11-343H5.4 is cross-mappable with RPS14 (ENSG00000164587),
a protein-coding gene in chromosome 5 near the putative trans-eQTL variant.
There was also a cis-association between the variant and RPS14. k-mers from
RPS14 indeed map to the region within RP11-343H5.4, where we observed a
non-zero number of reads. Interestingly, in this case, read mapping appears
to be genotype-dependent - the variant at chr5:149826526 alters sequence
such that it would lead to reads from RPS14 uniquely, but likely incorrectly,
mapping to RP11-343H5.4.
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trans p ≤ 1.68e-104
cis p ≤ 9.96e-8
Figure 2.7: An example of likely false positive trans association between the vari-
ant chr5:149826526 and the gene RP11- 343H5.4. The coverages (reads per million,
RPM) of the trans-eGene RP11-343H5.4 (top) and its cross-mapping gene RPS14 (bot-
tom) in Thyroid are shown along with their exons and UTRs (black lines below the
coverage plot), and mappability of 75-mers. The regions of mappability less than 1.0






































































































































































Figure 2.8: Trans-eQTL replication. (A) Q-Q plot, replication p-values from DGN for
variant-gene pairs discovered in GTEx Whole Blood, grouped by cross-mappability.
(B) The fraction of significant eQTLs in each GTEx tissue (row) replicated in another tis-
sue (column) at FDR ≤ 0.05, for cross-mappable eQTLs (left) and not cross-mappable
eQTLs (right).
enriched for false-positives, are highly replicable between datasets. This mis-
leading replication occurs because it is driven by the underlying sequence
of the genome, and similar alignment errors frequently occur regardless of
tissue and study. We showed this by measuring the replication between the
significant trans-eQTLs detected at FDR ≤ 0.05 from whole blood from GTEx
and whole blood data from the DGN study (Battle et al., 2014). To avoid the
effects of linkage disequilibrium, we tested for trans-association in DGN only
for the best variant per GTEx trans-eQTL gene (with the lowest p-value in
GTEx), where both the variant and the gene were present in the DGN data. At
FDR ≤ 0.05, only 10.71% (3 out of 28) non-cross-mappable trans-eQTLs were
replicated in DGN while 31.25% (5 out of 16) cross-mappable trans-eQTLs
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were replicated. The Q-Q plot in Figure 2.8A shows that cross-mappable trans-
eQTLs were more likely to be replicated compared to non-cross-mappable
ones. We observed the same phenomenon when we attempted to replicate
significant trans-eQTLs detected from one GTEx tissue in other GTEx tissues.
On average, 63.0% (range: 50.3-70.2%) and 16.3% (range: 7.6-25.1%) of cross-
mappable and non-cross-mappable trans-eQTLs, respectively, were replicated
(Figure 2.8B). This suggests that replication of a trans-eQTL does not necessar-
ily indicate a true positive. Overall, we suggest that regardless of replication,
cross-mappable trans-eQTLs require further investigation to establish that
they arise from biological regulation rather than alignment artifacts.
2.3.2 Effect of cross-mappability in co-expression analysis
Next, we evaluated evidence that alignment errors between genes can cause
spurious correlation between gene expression levels (co-expression). If align-
ment errors did not affect co-expression analysis, we would expect that the
distribution of pairwise correlation between cross-mappable genes would
not deviate from that between non-cross-mappable genes. To test this, we
used the gene expression data in five tissues from GTEx v7 after correction for
covariates and latent confounders (see Methods). For each tissue, we selected
a random set of 10,000 non-cross-mappable gene pairs and a random set of
10,000 cross-mappable gene pairs chosen with probability proportional to their
cross-mappabilities (sampling probability proportional to cross-mappability
ensures sampling from the whole cross-mappability range, as opposed to just
from the massive number of low cross-mappability pairs). Then we computed
40
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Muscle − Skeletal, p ≤ 1.6e-3
Skin − Sun Exposed, p ≤ 7.5e-9
Testis, p ≤ 1.7e-10
Thyroid, p ≤ 4.7e-5
Whole Blood, p ≤ 3.9e-3
Cross−mappable Not cross−mappable
Figure 2.9: Effect of cross-mappability on co-expression. (A) Comparison of co-
expression between randomly drawn pairs of cross-mappable genes and not cross-
mappable genes. Each violin plot shows the distribution of the absolute Pearson
correlation (y-axis) between corrected gene expression levels of randomly drawn
10,000 gene pairs in a tissue (color). P-value of the Wilcoxon test to determine whether
cross-mappable genes are more correlated than not cross-mappable genes in each
tissue is shown in the legend. (B) Fraction of top co-expressed genes that are cross-
mappable and thus potential false positives.
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the absolute Pearson correlation (|r|) between expression levels of the genes
in each randomly selected pair. We found that expression levels of cross-
mappable genes were more correlated than expression levels of non-cross-
mappable genes (median p across tissues ≤ 4.7 × 10−5, Wilcoxon rank-sum
test, Figure 2.9A). The difference was more significant when uncorrected data
were used (median p ≤ 1.3 × 10−74) We also observed that the correlation
coefficient tends to increase with increasing levels of cross-mappability be-
tween genes (Figure 2.10), indicating a high rate of false co-expression in the
most highly cross-mappable genes. The increased correlation between cross-
mappable genes was observed even after discounting genes from same gene
family (Figure 2.11), somewhat alleviating concerns that our observations
were due to exclusively true functional relationships. We observed a similar
pattern using data from an independent RNA-seq study, DGN (Figure 2.12).
To demonstrate the impact of this pattern on a realistic genome-wide co-
expression analysis, we evaluated how many of the top-most correlated gene
pairs in each GTEx tissue suffer from cross-mappability. We observed that
cross-mappable pairs of genes are over-represented among the top hits, with
gene pairs ordered by the absolute Pearson correlation after excluding pairs
of genes whose genomic coordinates actually overlap (Figure 2.9B). Overall,
the impact of cross-mappability on co-expression appears to be less than on
trans-eQTL analysis, but the phenomenon may still require consideration


























































































































































































































































































































● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
● ● ● ●
●
Skin - Sun Exposed











































































































































































































































































































































































































































































































































































































































































● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
● ● ● ●
●
Muscle - Skeletal





















































































































































































































































































































































Figure 2.10: Correlation between random gene pairs increases with cross-
mappability. Gene pairs available in each tissue were categorized into 22 groups
(x-axis) based on quantiles. A quantile group "q1 − q2(n)" represents gene pairs of
(q1 ∗ 100, q2 ∗ 100]-th percentile of cross-mappability with a total of n pairs. In order
to visualize the impact of the highest range of cross-mappability, the rightmost nine
quantile groups were selected in such a way that each contains about a certain num-
ber of pairs: (from right) 2,000, 2,000, 2,000, 2,000, 2,000, 5,000, 10,000, 25,000, 50,000.
The leftmost quantile group "0" represents gene pairs which are not cross-mappable.
From each group, 1,000 gene pairs were randomly selected where the probability of
drawing a pair was proportional to its cross-mappability. Each violin plot shows the
distribution of absolute Pearson correlation (y-axis) between corrected expressions of
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Figure 2.11: Increased correlation between cross-mappable genes is not exclu-
sively due to sequence similarity between genes from same gene family. Here,
two genes in the same HGNC gene family were artificially excluded from cross-
mappable pairs. We computed the absolute Pearson correlation between gene pairs
within different groups as described in Figure 2.9A and Figure 2.10. Note: gene
family information was downloaded from www.genenames.org. A-B) Comparison
of co-expression between 10,000 randomly drawn pairs of cross-mappable and not
cross-mappable genes in Muscle – Skeletal (A) and Whole Blood (B). C-D) Random
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Figure 2.12: Co-expression analysis using gene expression data from DGN. A)
Comparison of co-expression between 10,000 randomly drawn cross-mappable and
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Figure 2.13: Effects of varying k-mer length and the number of mismatches al-
lowed. Cross-mappability among the top GTEx trans-eQTLs when A) 75-mers (in-
stead of 36-mers) from UTRs were used, B) a maximum of 3 (instead of 2) mismatches
were allowed. 67.2% and 76.1% of the significant trans-eQTLs remain cross-mappable
in (A) and (B), respectively, compared to 75.14% using 75-mers from exons and
36-mers from UTRs with 2 mismatches in the original analysis. In both cases, cross-
mappable trans-eQTLs still tend to be the most highly significant.
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2.3.3 Impact of alternative quantification and parameter set-
tings
We have made several versions of our cross-mappability resources publicly
available for the human genome (hg19 and GRCh38) (Saha & Battle, 2019b),
and also published code in Github (Saha & Battle, 2019a). Researchers should
carefully choose settings according to the study design and goals. Genome
version and gene annotations can be directly matched, but other parameter
choices such as k and the maximum number of mismatches allowed in align-
ment may affect the detection of false positives. Small values of k will produce
more conservative cross-mappability scores, but large k may not correctly
handle small exons or UTRs. For example, if 75-mers (instead of 36-mers)
were used from UTRs, a smaller proportion of trans-eQTLs (67.2% instead of
75.14%) would appear as cross-mappable in GTEx, although cross-mappable
trans-eQTLs would still tend to be most highly significant (Figure 2.13A).
Similarly, increasing the number of mismatches allowed in k-mer alignment
results in an increased number of cross-mappable trans-eQTLs (Figure 2.13B).
For convenience, k and the number of mismatches are configurable in our
software so that, if needed, one can compute cross-mappability scores with
settings appropriate for a given study.
We also note that utilization of improved alignment and quantification
methods to generate gene expression data may also be helpful to avoid false
positives. For example, quantification of gene expression levels using RSEM
(Li & Dewey, 2011), an expectation maximization based quantification tool,
results in a smaller fraction of false positive trans-eQTLs (60.17%) than that
47
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Figure 2.14: Effects of EM-based quantification methods. A) We computed trans-
eQTLs using RSEM-quantified data. A total of 27,035 trans-eQTLs were detected at
FDR ≤ 0.05, 60.17% of which were cross-mappable compared to 75.14% with RNA-
SeQC-quantified data. The plot shows the fraction of cross-mappable trans-eQTLs
among the top significant variant-gene pairs (ordered by increasing FDR) in each
tissue (color). Here, we observed a modest improvement by RSEM. B) Fraction of
top co-expressed genes that are cross-mappable and thus potential false positives.
Cross-mappable gene pairs still appear abundant in most correlated genes of multiple
tissues.
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using RNA-SeQC (75.14%). However, potential false positives due to cross-
mappability still remain abundant in both trans-eQTL and co-expression
studies (Figure 2.14).
2.4 Discussion
Misalignment of short sequencing reads has the potential to induce false posi-
tives in association studies. For RNA-seq, both trans-eQTL and co-expression
analyses are susceptible to these artifacts, related to false positives in mi-
croarray analysis due to probe cross-hybridization. This is readily apparent
from the enrichment of processed pseudogenes among the top hits for such
association studies, but misalignment can affect protein-coding genes as well.
Our results demonstrate that trans-eQTL associations in a standard pipeline
are dominated by potential false-positives due to sequence similarity and
replication rates between studies may be artificially inflated due to this pat-
tern. Additionally, genes with sequence similarity display more correlated
expression levels, and mapping errors should be considered in co-expression
analysis as well.
Our results do not imply that all instances of co-expression or trans-eQTL
associations arising from genes with sequence similarity are in fact false pos-
itives. Genes with sequence similarity also sometimes have true functional
relationships. Pseudogene transcripts may interact with coding transcripts,
and some associations with pseudogene expression may reflect true regula-
tory relationships (Pink et al., 2011). Furthermore, the background (random)
rate of sequence similarity between any two regions in the human genome
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is above zero; that is, a hit may occur between regions of sequence similar-
ity by chance, even when no actual misalignment of reads has taken place.
However, we believe the exceedingly high fraction of cross-mappable regions
among trans-eQTLs from a naive analysis warrants suspicion that these hits
are predominantly false positives. Researchers should consider their partic-
ular application and tolerance for false negatives and false positives when
applying filters targeting alignment errors. Other information, such as base-
level coverage plots and outside functional information can help disambiguate
particular cases of interest.
Extensions, modifications, and other approaches related to this problem
should also be considered. First, specifics of study design, and in particular
sequencing read length, should be taken into account when using our data
to filter potential false positives. If read length is much shorter or longer
than our k-mer setting, our existing data may be insufficient and new map-
pability and cross-mappability estimates should be derived. In the initial
resource provided, we used k-mer alignment to the genome, which does not
directly handle splice junctions in transcriptomic data (and also limits appro-
priate k-mer length even for studies with longer reads). Alignment to the
transcriptome or splice-aware alignment may offer future improvements, but
computational cost and inaccuracies due to incorrect annotation will have
to be evaluated. Our observations and methods may be relevant to analyses
of other functional genomic data as well, including detection of interactions
from HI-C, and detection of associations with data types such as ATAC-seq
or ChIP-seq. Other approaches, such as filtering reads themselves before
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quantification can also be applied if raw reads rather than quantified data are
available and tractable (van de Geijn et al., 2015).
Our evaluation provides evidence that misalignment of reads should be
considered as a potential source of false positives in association studies, partic-
ularly for trans-eQTL analysis. The resources we provide can be used directly
to filter potential false positives, or the ideas presented may be tuned and
adapted to new studies and data types.
2.5 Data and code availability
Pre-computed cross-mappability resources for human genomes (hg19 and
GRCh38) are available on FigShare.
Github repository to compute cross-mappability: https://github.com/battle-
lab/crossmap.




Joint regulation of transcription
and alternative splicing
In the previous chapter, we reported a source of false positives in transcription
regulation studies. In this chapter, we present our work on joint regulation of
transcription and alternative splicing.
Transcription is the process by which a double-stranded DNA is copied
(transcribed) to produce single-stranded precursor messenger RNAs (pre-
mRNAs) containing codes for proteins (Figure 1.3). It determines the amount
of RNA and consequently the amount of protein produced from each gene in
a given context. The total amount of RNA generated from a gene is generally
called total expression (TE) or simply expression of the gene. Every organism
needs to maintain proper gene expression levels to perform necessary activi-
ties.
RNA splicing is an important process in which introns are removed from
each pre-mRNA and exons are joined together to form a mature mRNA or
simply mRNA. By varying the composition of exons, the splicing process
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may produce different mature mRNAs from the same pre-mRNA. This phe-
nomenon is known as alternative splicing (Figure 1.3). Each type of mature
mRNA produced from the same gene through alternative splicing is called
an isoform. Importantly, each isoform contains a different sequence and gen-
erally produces different types of proteins. In fact, alternative splicing is an
essential mechanism in complex organisms, including humans, to produce
many different proteins for all necessary tasks. A mis-splicing can effectively
alter downstream proteins causing diseases. According to one study, about
one-third of all disease-causing mutations alter RNA splicing (Lim et al., 2011).
According to another study (Kahles et al., 2018), alternative splicing events
are up to 30% more common in tumor samples compared to control samples,
underscoring the importance of understanding the regulation of alternative
splicing.
While a few splicing factors are known, specific regulatory genes involved
in splicing regulation remain poorly understood relative to transcription
(Melé et al., 2015; Scotti & Swanson, 2015). In this project, led by me, we ex-
tended the framework of co-expression networks to jointly study transcription
and splicing and the interplay between them. Our main contributions are the
following:
• We developed a framework called Transcriptome-Wide Networks (TWNs)
for combining total expression and relative isoform levels into a sin-
gle sparse network, capturing the interplay between the regulation of
splicing and transcription.
• We built TWNs for sixteen human tissues, and found that hubs in these
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networks were strongly enriched for splicing and RNA binding genes,
demonstrating their utility in unraveling regulation of splicing in the
human transcriptome.
• Next, in collaboration with the Engelhardt Lab at Princeton University,
we used a Bayesian biclustering model that identifies network edges
unique to a single tissue to reconstruct Tissue-Specific Networks (TSNs)
for 26 distinct tissues.
• Finally, we found genetic variants associated with pairs of adjacent
nodes in our networks, supporting the estimated network structures
and identifying 20 genetic variants with distant regulatory impact on
transcription and splicing.
This work was published in Genome Research (Saha et al., 2017), and this
chapter is based on the published article.
3.1 Introduction
Gene co-expression networks are an essential framework for elucidating gene
function and interactions, identifying sets of genes that respond in a coordi-
nated way to environmental and disease conditions, and highlighting regu-
latory relationships (Penrod et al., 2011; Xiao et al., 2014; Yang et al., 2014).
Each edge in a co-expression network reflects a correlation between two tran-
scriptional products, represented as nodes (Stuart et al., 2003). Most gene
co-expression networks focus on correlation between total gene expression
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levels, with edges representing transcriptional co-regulation. However, post-
transcriptional modifications, including alternative splicing, are important in
creating a transcriptome with diverse biological functions (Matlin et al., 2005).
Mutations that lead to disruption of splicing play an important role in tissue-
and disease-specific pathways (DeBoever et al., 2015; Lee et al., 2012; Li et al.,
2016d; López-Bigas et al., 2005; Wang et al., 2008; Ward & Cooper, 2010).
While a number of splicing factors are known, regulation of splicing and
specific regulatory genes involved remain poorly understood relative to the
regulation of transcription (Melé et al., 2015; Scotti & Swanson, 2015). Al-
though abundance of different isoforms can be influenced by processes includ-
ing usage of alternative transcription start or end sites and RNA degradation,
variation in isoform levels is often the direct result of alternative splicing. RNA
sequencing now allows quantification of isoform-level expression, providing
an opportunity to study regulation of splicing using a network analysis. How-
ever, current research estimating RNA isoform-level networks (Li et al., 2016a;
Li et al., 2015; Li et al., 2014) has focused on total expression of each isoform,
and the resulting network structures do not distinguish between regulation
of transcription and regulation of splicing in an interpretable way. Initial
work on clustering relative isoform abundances has also been explored (Dai
et al., 2012; Iancu et al., 2015), but does not support discovery of fine-grained
network structure or identification of regulatory genes. Neither approach has
been applied to large RNA-seq studies for network reconstruction in diverse
tissues.
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Another important gap in our interpretation of regulatory effects in com-
plex traits is a global characterization of co-expression relationships that are
only present in a specific tissue type. Per-tissue networks have been estimated
for multiple tissues (Pierson et al., 2015; Piro et al., 2011), but, critically, these
analyses do not directly separate effects unique to each tissue from shared ef-
fects found in all or many tissues. Recent studies have recognized the essential
role that tissue-specific pathways play in disease etiology (Greene et al., 2015),
but have developed these per-tissue networks by aggregating single tissue
samples across multiple studies. However, differences in study design, techni-
cal effects, and tissue-specific expression make cross-study results difficult to
interpret mechanistically, with large groups of genes expressed in similar tis-
sues and studies tending to be highly connected rather than including sparse
edges that detail tissue-specific network structure (Lee et al., 2004).
In this work, we reconstruct co-expression networks from the Genotype
Tissue Expression (GTEx) v6 RNA sequencing data (The GTEx Consortium,
2015, 2017), including 449 human donors with genotype information and
7,310 RNA sequencing samples across 50 tissues. We apply computational
methods designed to reveal novel relationships between genes and across tis-
sues as compared to previous analyses, specifically addressing two important
goals in regulatory biology: identification of edges reflecting regulation of
splicing, and discovery of edges arising from gene relationships unique to
specific tissues. We introduce a new framework, Transcriptome Wide Networks
(TWNs), which capture gene relationships that reflect regulation of alterna-
tive splicing in an interpretable model. We built TWNs to identify candidate
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regulators of both splicing and transcription across sixteen tissues. Next, we
identified Tissue-Specific Networks (TSNs) for 26 tissues, where each network
edge corresponds to a correlation between genes that is uniquely found in a
single tissue. We study the biological interpretation of both network types by
quantifying enrichment of known biological functions among well-connected
nodes. Finally, we use genetic variation to validate network edges from each
network by testing associations between a regulatory variant local to one
gene with that gene’s network neighbors. Interpretation of regulatory and
disease studies will benefit greatly from these networks, providing a much
more comprehensive description of regulatory processes including alternative
splicing across diverse tissues.
3.2 Methods
3.2.1 Transcriptome-wide network (TWN)
We developed a method to estimate Transcriptome-Wide Networks (TWNs)
from RNA-seq data that captures the co-regulation of alternative splicing, in
addition to co-expression, across multiple genes.
We first quantified both total expression level (TE) and isoform expression
levels of each gene in each RNA-seq sample and then computed isoform ratios
(IR), representing the relative abundance of each isoform with respect to the
total expression of the gene (Figure 3.1A). Unlike a traditional co-expression
network that includes only one type of nodes generally corresponding to total
expression levels, we included two types of nodes in a TWN, corresponding
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Figure 3.1: Transcriptome-Wide Network conceptual framework. (A) Schematic of
the effect of a splicing regulator on inclusion of a cassette exon, and resulting total
expression and isoform ratios of the target gene. Higher expression of a splicing
regulator S (first row) results in relatively more transcripts of isoform-1 and fewer
of isoform-2. Total expression level is constant (5), but isoform ratios are different
(0.4 and 0.6) as splicing factor S levels change. (B) Left: Standard isoform-level
network and TWN representation when a transcription factor (Gene 1 with 2 isoforms)
regulates transcription of its target (Gene 2 with 3 isoforms). Right: Standard isoform-
level network and TWN representation when a splicing factor (Gene 1 with 2 isoforms)
regulates splicing of its target (Gene 2 with 3 isoforms). (C) We created a sparse
precision matrix Θ (inverse covariance) from the sample covariance matrix using
graphical lasso. A non-zero value (Θij) in the precision matrix denotes an edge
between i-th feature and j-th feature in the network. (D) Different types of hubs in a
TWN. Dotted rectangles group together isoform ratios for different isoforms of the
same gene.
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information about isoforms, a TWN can capture splicing regulation, which a
traditional co-expression network cannot.
A TWN is also critically different from a standard correlation network of
isoform expression levels (not isoform ratios) to distinguish correlation due
to transcription and alternative splicing. An isoform-level network cannot
distinguish an edge due to transcription from an edge due to splicing, because
both transcription and splicing affect the expression level of an isoform. In
contrast, splicing affects isoform ratio, but not total expression, and transcrip-
tion affects the total expression level, but not isoform ratio. A TWN offers an
interpretable framework to distinguish between transcription and splicing,
and to reveal the interplay between both mechanisms. For example, to repre-
sent the relationship between a transcription factor (TF) and expression of a
target gene, where all isoforms are equally affected, a standard isoform-level
network would require edges from each isoform level of the TF to each iso-
form level of the target (Figure 3.1B). The same structure would also represent
the relationship between a splicing factor (SF) and its target gene where the
transcription is grossly unaffected but the relative production of isoforms is
altered.
Taking both total expression levels and isoform ratios as features, we es-
timated a sparse precision matrix (Θ) from the sample covariance matrix (S)
using a graphical lasso (Friedman et al., 2008) approach (Figure 3.1C). A non-
zero entry in the sparse matrix implies that the corresponding two nodes are
correlated after controlling for other nodes. We modified the standard graphi-
cal lasso to penalize different types of edges by different weights. Specifically,
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we optimized the following objective:
Θ̂ = argmin
Θ
− log det Θ + tr(SΘ) + ∥Λ ◦ Θ∥1 (3.1)
where the entry in r-th row and c-th column of the penalty matrix Λ was
Λrc =
⎧⎪⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎪⎩
λd if r = c
λs if r ̸= c and gene(r) = gene(c)
λtt if gene(r) ̸= gene(c) and type(r) = type(c) = ‘TE’
λti if gene(r) ̸= gene(c) and {type(r), type(c)} = {‘TE’,‘IR’}
λii if gene(r) ̸= gene(c) and type(r) = type(c) = ‘IR’.
(3.2)
Here, type(k) denotes whether or not the k-th feature represents total
expression (‘TE’) or isoform ratio (‘IR’). gene(k) denotes the gene that the k-th
feature belongs to.
We did not penalize diagonal entries (λd = 0), and we put a small non-
zero penalty (λs = 0.05) for edges between distinct features belonging to the
same gene, such as distinct isoforms of the same gene. We selected the other
penalties (λtt, λti, λii) in such a way that the network had a scale-free topology
with a reasonable number of edges.
3.2.2 Tissue-specific network (TSN)
A per-tissue TWN contains both shared and tissue-specific co-expression re-
lationships between genes, without making any distinction between them,
reflecting the full gene network in each tissue. To directly assess the tissue-












































Figure 3.2: Tissue-specific network (TSN) conceptual framework. BicMix, a
Bayesian sparse factor analysis based model, decomposes a gene-by-sample expres-
sion matrix (Y) into a gene-by-K loading matrix (Λ), a K-by-sample factor matrix (X),
and a gene-by-sample residual matrix (ϵ), where K is the number of latent factors.
BicMix induces sparsity in both Λ and X, and thus identifies clusters of co-expressed
genes that are co-expressed in a subset of samples. Using the gene loadings corre-
sponding only to factors with non-zero values in a single tissue, a precision submatrix
(∆) corresponding to the non-zero genes can be estimated; standardized, these val-
ues correspond to partial correlation. Thresholding these partial correlations using
FDR, each non-zero value corresponds to an edge between a pair of genes in the
tissue-specific gene co-expression network. By estimating the gene covariance matrix
using only components with non-zero values among the tissue of interest in BicMix,
we explicitly remove all covariation that is found outside of the tissue of interest.
This shared covariation may also include covariation due to batch effects, population
effects, cross-tissue expression QTLs, or cellular housekeeping pathways; while this
shared variation is captured in the BicMix model, it is ignored when building the
TSNs.
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framework, BicMix (Gao et al., 2016), and reconstructed tissue-specific net-
works (Figure 3.2). BicMix uses a sparsity-inducing prior to differentiate
between gene co-expression relationships specific to a single tissue and those
shared across tissues, simultaneously controlling for batch effects, population
structure, and shared individual effects across tissues (Gao et al., 2016).
3.2.3 Data from GTEx project
RNA-seq data: We collected RNA sequencing and genotyping data from
the Genotype-Tissue Expression (GTEx) consortium (The GTEx Consortium,
2015). GTEx obtained tissue samples (averaging about 28 per individual) from
postmortem donors, between ages 21 and 70, BMI 18.5 to 35, and not under
exclusionary medical criteria such as whole-blood transfusion within 24 hours
or infection with HIV. 76 base pair (bp) pair-ended mRNA sequencing was
performed with Illumina HiSeq 2000 following the TrueSeq RNA protocol,
resulting approximately 50 million reads per sample. After quality controlling,
we aligned the RNA-seq reads using the STAR aligner (Dobin et al., 2013) in 2-
pass mode with GENCODE v.19 annotation retaining only uniquely mapping
reads. We then performed transcript and gene quantification using RSEM
v1.2.20 (Li & Dewey, 2011). We used RNA-seq data across 50 tissues in 449
individuals.
Genotype data: Approximately 1.9 million SNPs were genotyped using whole
blood samples with Illumina HumanOmni 2.5M and 5M BeadChips. Ad-
ditional variants were imputed using IMPUTE2 (Howie et al., 2009). The
genotypes were filtered for MAF ≥ 0.05, leaving approximately 6 million
62
variants.
3.2.4 Pre-processing for per-tissue TWNs
We considered only protein-coding genes on the autosomes and Chromosome
X to construct TWNs in all tissues. We used genes and isoforms with at least
10 samples with ≥ 1 TPM and ≥ 6 reads. We filtered out genes where the
Ensembl gene ID did not uniquely map to a single HGNC gene symbol. Iso-
form ratio was computed by using annotated isoforms in GENCODE V19
annotation, and undefined isoform ratios (0/0, when none of the isoforms
was expressed) were imputed from the mean ratio per isoform across indi-
viduals. Each gene’s least abundant isoform was excluded to avoid linear
dependency between isoform ratio values. We log-transformed the total ex-
pression data and standardized both total expression levels and isoform ratios.
To correct hidden confounding factors, we applied HCP (Hidden covariates
with prior) (Mostafavi et al., 2013), whose parameters were selected based
on an external signal relevant to regulatory relationships. Namely, we se-
lected parameters that produced maximal replication of an independent set of
trans-eQTLs from meta-analysis of a large collection of independent whole
blood studies (Westra et al., 2013). For both total expression levels and isoform
ratios of genes in all tissues, the best HCP parameters (k = 10, λ = 1, σ1 = 5,
σ2 = 1), which consistently reproduced a largest subset of the gold-standard
trans-eQTLs in GTEx whole blood samples even when subsetting the number
of samples, were used for correcting data. Finally, quantile-normalization to a
standard normal distribution was applied.
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To avoid spurious associations due to mis-mapped reads, we filtered out
genes with mappability (Saha & Battle, 2018) < 0.97 and their isoforms. We
also filtered out isoforms of a gene if the mean IR of the most dominant
isoform was ≥ 0.95.
For computational tractability, we selected 6,000 genes and 9,000 isoforms
in each tissue from available genes and isoforms that passed other filtering
steps. To do so, we first considered genes or isoforms if > 10 samples have
TPM > 2 or reads > 6. To obtain the final set of genes, we first considered
the top 9,000 genes based on their average expression levels and then selected
the top 6, 000 highly variable genes across individuals. Similarly, to obtain
the final set of isoforms, we first considered the 13, 500 genes with the highest
expressed isoform levels on average. We reduced this to 11,250 genes based on
the entropy of isoform ratios across individuals, normalized by the maximum
entropy possible with the same number of isoforms, and finally took the top
9,000 most highly variable isoforms in terms of TPM values. On average, the
finally selected isoforms for each tissue belong to 4,357 unique genes.
3.2.5 Pre-processing for TSNs
We normalized the gene level TPM data for GC content, length, and depth. For
each tissue, we removed genes that had zero read counts in more than 90% of
samples. We took the intersection of all remaining genes across the 50 tissues,
and only used those 15,589 genes for the analysis. All 50 tissue expression
matrices were appended together and subsequently quantile normalized
within each gene across all tissues.
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3.2.6 TWN hub ranking
We ordered the network hubs by degree centrality for each tissue according to
the number of unique gene-level connections to avoid the effect of different
number of isoforms per gene. To do this, we created a gene-level network
from the original TWNs by keeping TE nodes as they were and grouping all
isoforms of the same gene together to form a compound IR node. We put an
edge between a compound IR node and a TE node (or another compound
TE node) if any isoform of the compound had an edge with the TE node (or
any isoform of the other compound) in the original TWN, and the weight
was equal to the sum of absolute weights of all such edges in the original
TWN. TE-TE and IR-TE hubs were ordered by the number of TE nodes they
were connected with. TE-IR and IR-IR hubs were ordered by the number of
compound IR nodes they were connected with. If multiple hubs had the same
number of connections, ties were broken by the sum of corresponding edge
weights.
3.2.7 TF-target enrichment in TE-TE edges of TWN
We downloaded transcription factors (TFs) and their known targets from
ChEA (Lachmann et al., 2010). We measured the number of known TF-target
relationships captured by a network, i.e., a TF and its target’s total expression
nodes were directly connected with each other. We generated the null dis-
tribution of the number of known TF-target relationships by computing the
same test statistics for random networks, generated by permuting gene names
among network nodes 1000 times. Then, we computed the empirical p-value
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as the proportion of those iterations for which the random network had at
least as many known TF-Target edges as the test network. We fitted a Weibull
distribution on the log(1+fraction of known TF-Target edges) to quantify the
p-values.
3.2.8 TWN hubs specific to a group of related tissues
To find hubs specific to a group of tissues, we used rank-product to rank hubs
in both the target group of tissues, and all other tissues, separately. Then, we
normalized ranks so that the top- and bottom-ranked hubs have a score of 1
and 0, respectively. Let the normalized rank of a gene in the target group of









will be high if it ranks high in the target group, but low in other tissues.
We computed related tissue specific hubs for five groups of related tissues:
1) skin– sun exposed and skin – not sun exposed, 2) adipose – subcutaneous, adipose
– visceral and breast – mammary, 3) heart – left ventricle and skeletal muscle, 4)
esophagus – mucosa and esophagus – muscularis, and 5) artery – aorta and artery –
tibial.
Cis-eQTLs from TSNs
For each tissue in which we recovered a TSN, we used the same set of genes
and expression values as described for TSN creation, prior to taking the
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intersection of genes across all tissues. PEER factors were used to quantify
effects of unobserved confounding variables (Stegle et al., 2012). We optimized
the number of PEER factors by tissue to a test chromosome (Chromosome
11) to maximize the number of identified cis-eQTLs. The linear model of
Matrix-eQTL (Shabalin, 2012) was used to test all SNPs within the 100 kb
window of a gene’s transcription start site (TSS) or end site (TES) using an
additive linear model. We included in association mapping a tissue-specific
number of PEER factors, sex, genotyping batch, and three genotype principal
components. The correlation between SNP and gene expression levels was
evaluated using the estimated t-statistic from this model. False discovery rate
(FDR) was calculated using Benjamini-Hochberg (BH) method. We used these
cis-eQTLs for the trans-eQTL analysis for the TSN edge replication described
below.
Trans-eQTLs from TSNs
We computed trans eQTLs in two ways. First, we found the best cis-associated
variant per gene (smallest p-value, from the cis-eQTLs described in the pre-
vious paragraph) in that tissue, if one existed, and measured association
between that variant and every neighbor of that gene in the TSN using the
linear model of Matrix-eQTL (Shabalin, 2012). Second, we measured associ-
ation between all variants within 20 kb of a gene’s TSS and TES with each
neighbor in the network using the linear model of Matrix-eQTL (Shabalin,
2012). In both approaches, we controlled for the first three genotype PCs, sex,
and platform, and used BH FDR ≤ 0.2 for multiple testing correction.
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Trans-splicing QTLs from TWNs
We computed trans-splicing QTLs using two approaches. In the first ap-
proach, we used the best cis-associated variant per gene (smallest p-value)
located within 1 Mb from the transcription start site (TSS) of the gene (The
GTEx Consortium, 2017). Then for every TE node connected with an IR
node in the network, we measured association between the gene’s best cis-
associated variant and all the isoform ratio neighbors using the linear model
of Matrix-eQTL (Shabalin, 2012), controlling for the first three genotype PCs
and genotype platform. We corrected for false discovery (BH FDR ≤ 0.05). In
the second approach, for each of the top 500 TE-IR hubs, we took all variants
within 20 kb of the TSS and tested their association with isoforms located on
a different chromosome and connected with the TE hub using Matrix-eQTL.
Here, we used FDR ≤ 0.2 for multiple tests correction.
3.3 Results
3.3.1 Reconstructing transcriptome-wide networks across hu-
man tissues
We aimed to capture a global view of transcription and splicing regulation
across the transcriptome of diverse human tissues. Using RNA-seq data
from the Genotype-Tissue Expression (GTEx) project (v6) (The GTEx Consor-
tium, 2017), we reconstructed TWNs independently for each of the sixteen
tissues with samples from at least 200 donors. Before applying our method,
we corrected expression data from each tissue for known and unobserved
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Figure 3.3: GTEx transcriptome-side networks summary. For each tissue, number
of edges and number of hub nodes (≥ 10 neighbors), segmented by the type of nodes
connected by each edge.
confounding factors using HCP (Mostafavi et al., 2013), and all total expres-
sion and isoform ratio values were separately projected onto quantiles of a
standard normal distribution. For computational tractability, we decided to
use 6,000 genes and 9,000 isoforms for each tissue from available genes and
isoforms. After applying graphical lasso, we excluded some edges from our
networks for quality purpose and interpretability. Specifically, we excluded
edges between nodes belonging to the same gene for downstream analysis.
We also excluded edges between cross-mappable genes (Saha & Battle, 2018)
and between genes with overlapping positions in the reference genome to
avoid alignment and mapping artifacts. On average, each TWN contained
60,697 edges, with 24,527 between TE nodes (TE-TE), 18,539 between IR nodes
(IR-IR), and 17,631 edges connecting TE and IR nodes (TE-IR) (Figure 3.3).
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Figure 3.4: Robustness of TWN estimation for varying regularization parameters
and sample size. We varied one of three variables at a time (regularization parameter
λtt, regularization parameter λti, or sample size) keeping other variables the same as
actually used, and re-estimated TWNs in whole blood. We then computed Tanimoto
coefficients between edge weights of every pair of re-estimated TWNs categorized
by type of edge: edge between two total expression nodes (TE-TE), between a total
expression and an isoform node (TE-IR), and between two isoform nodes(IR-IR). A)
Tanimoto coefficients for varying λtt. Tanimoto coefficients between the selected
λtt(0.4) and nearby choices (0.35, 0.4) are very high in each category (0.86 and 0.83
for TE-TE, 0.93 and 0.96 for TE-IR, 1 and 1 for IR-IR, respectively). B) Tanimoto
coefficients for varying λti = λii. Here, the selected λti = λii was 0.25. C) Tanimoto
coefficients for varying sample size. In each run, we randomly selected 90 % samples
and re-estimated TWNs using the regularization parameters fixed to the same as
actually used.
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Reconstructing co-expression networks requires estimation of a large num-
ber of parameters (in our case, over 2× 108) despite a small number of samples
(≤ 430); robustness and replicability of network edges are thus important
considerations. The estimated networks were robust to change in regular-
ization parameters and sample size in terms of similarity between networks
measured by Tanimoto coefficient (Figure 3.4).
While there are not other large-scale RNA sequencing data sets for most
GTEx tissue types, we replicated relationships identified by our GTEx whole
blood TWN using an independent whole blood RNA-seq data set on 922
individuals of European ancestry from the Depression Genes and Networks
study (DGN) (Battle et al., 2014; Mostafavi et al., 2014). First, we tested
whether TE and IR nodes connected by an edge in the GTEx whole blood
TWN were also correlated in DGN. For all edge types, we found that a higher
fraction of gene pairs connected by an edge in the GTEx TWN were correlated
in DGN compared to genes from random networks (84.7% versus 45.6%,
31.9% versus 5.9%, and 20.9% versus 2.6% for TE-TE, TE-IR and IR-IR edges,
respectively; FDR ≤ 0.05; Figure 3.3B). Next, we reconstructed a TWN from
DGN data over genes and isoforms common to both data sets. All pairs of
nodes connected directly or indirectly in the GTEx whole blood TWN had
significantly shorter network path distance in the DGN network compared
to the distance in the same network with the node labels shuffled (Wilcoxon
rank-sum test, p ≤ 2.2 × 10−16; Figure 3.5). This provides replication in
an independent sample for the same tissue, despite different alignment and
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Figure 3.5: Replication of networks in an independent RNA-seq dataset. A) Per-
centage of edges from GTEx whole blood TWN edges that were significantly corre-
lated in independent RNA-seq samples from DGN (Battle et al., 2014; Mostafavi et al.,
2014). B-D) Fraction of connected node pairs from the GTEx whole blood TWN with
a given distance between them in DGN TWN, categorized by node types: two total
expression nodes (B), a total expression node and an isoform ratio node (C), and two
isoform ratio nodes (D). In each plot, DGN networks are compared with random













































































































































Figure 3.6: Replication of TWN using ARACNE. With the same data as used for
TWNs, we reconstructed ARACNE networks from Spearman correlation based mu-
tual information matrix using minet R package for 16 tissues. Following similar
procedures as TWNs, we excluded edges between features of same gene, cross-
mappable genes, and position-overlapped genes from downstream analysis. A) For
TWNs and random networks, fraction of edges (y-axis) that were also present in
ARACNE network in matched tissue (x-axis). A high fraction of TWN edges (30.42-
46.34%, mean 37.72%), compared to random edges, were captured by ARACNE,
demonstrating replication of TWN relationships using an independent method. B)
Ratio of the number of edges in ARACNE network to the number of edges in TWN
(y-axis) of the matched tissue (x-axis). On average, each ARACNE network had 3.17
times as many edges as the matched TWN indicating that TWN potentially captures
direct relationships. C) Fraction of TWN edges (y-axis) that were also present in
ARACNE network in matched tissue (x-axis), categorized by edge types. On average,
38.70%, 27.48%, and 46.43% of TE–TE, TE–IR, and IR–IR edges, respectively, were
captured by ARACNE.
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TWN relationships were also replicated by substituting a second gene
regulatory network reconstruction method, ARACNE (Margolin et al., 2006) in
place of graphical lasso, using the same overall framework and quantification
of TE and IR levels in the GTEx data. ARACNE captured 37.73% of graphical
lasso edges on average, compared to the expected proportion (0.15%) of edges
captured at random (Figure 3.6), showing that the TWN signal is robust to
choice of network estimation method.
3.3.2 TWN hubs are enriched for regulators of splicing
To characterize the TWNs, we focused on network hubs, as hub genes tend to
be essential in biological mechanisms (Albert, 2005; Barabasi & Oltvai, 2004;
Jeong et al., 2001). Unlike traditional networks, TWNs have four categories
of hub genes that likely reflect different regulatory functions (Figure 3.1D).
For instance, a hub arising from a total expression node connected to a large
number of isoform ratio neighbors (TE-IR hub) may reflect a gene important
in regulation of alternative splicing. We identified the top hub nodes by degree
centrality – the number of edges per node – for each category. To avoid bias
due to different numbers of isoforms per gene, we measured degree centrality
of a node by the number of unique genes among neighboring nodes in each
category. Based on a threshold of ten or more neighbors, TWNs had a mean
of 1,853 “TE-TE" hub genes (total expression nodes connected to many total
expression neighbors) and 325 “TE-IR" hub genes (total expression nodes
connected to many isoform ratio neighbors) across tissues (Figure 3.3).
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Figure 3.7: Enrichment of candidate splicing regulators among TWN hubs. A)
In each TWN, the odds ratio and p-value of enrichment among the top 500 TE-IR
hub genes for GO annotations reflect RNA binding and RNA splicing. B) Among
consensus TE-IR hubs across all tissues, enrichment for GO annotations reflects RNA
binding and RNA splicing functions.
to be regulators of alternative splicing. For each tissue, we evaluated the
top TE-IR hubs for enrichment of Gene Ontology (GO) terms related to RNA
splicing, and observed a significant abundance of known RNA splicing genes
(annotated with GO:0008380) among the top TE-IR hubs. Indeed, 13 of 16
tissues (81.25%) showed significant enrichment of RNA splicing genes in
the top 500 TE-IR hubs (significance assessed at Benjamini-Hochberg (BH)
corrected p ≤ 0.05; median across all tissues p ≤ 6.22 × 10−4, Fisher’s exact
test), and every tissue had larger than unit odds ratio of RNA splicing genes
among the top hubs (Figure 3.7A). Enrichment was robust to choice of hub
degree threshold.
Next, we tested for enrichment of RNA-binding proteins, many of which
are known to be important regulators of RNA splicing and processing (Chen &
Manley, 2009; Wang & Burge, 2008; Witten & Ule, 2011). We found that RNA
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binding genes (annotated with GO:0003723) were also significantly enriched,
at BH corrected p ≤ 0.05, among the top TE-IR hubs of every tissue except
heart – left ventricle (median p ≤ 3.17 × 10−4; Figure 3.7A). Across all GO
terms, splicing, RNA binding, and RNA processing were consistently among
the most enriched for TE-IR hubs across tissues (Tables A.1 and Table A.2).
The replication network estimated from the DGN data also indicated relevant
enrichment among TE-IR hubs (RNA splicing: p ≤ 1.07 × 10−5, odds ratio 2.72;
RNA binding: p ≤ 2.5 × 10−11, odds ratio 2.37).
Many regulatory relationships are shared between tissues, and assessing
hubs across all tissues jointly may improve robustness (Ballouz et al., 2015).
Therefore, we identified TE-IR hubs shared across tissues (Table 3.1) using
rank-product (Zhong et al., 2014). We first ranked hub genes according to the
number of neighbors in each network. We then aggregated the ranks of those
genes across all networks by computing the product of these ranks, and sorted
genes to find the top TE-IR hubs (those with the largest number of neighbors
in the most tissues). We observed much stronger enrichment for RNA splicing
and RNA binding in the joint analysis than in individual tissues (Figure 3.7B).
Many of the top ranked TE-IR hubs shared across tissues are known
to regulate splicing. RBM14 (rank two), a RNA binding gene also known
as COAA, interacts with a transcription regulator TARBP2 to regulate splic-
ing in a promoter-dependent manner (Auboeuf et al., 2004; Auboeuf et al.,
2002). Another RNA binding gene PPP1R10 (rank four) has been implicated
in pre-mRNA splicing using mass spectrometry analysis (Du et al., 2014).
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SRRM2 (rank eight) and SRSF11 (rank nine) are also known splicing regula-
tors (Blencowe et al., 2000; Chen & Manley, 2009; Wu et al., 2006; Zhang &
Wu, 1996). For eleven of the top twenty cross-tissue TE-IR hubs, we found
previous work supporting a role in the regulation of splicing (Table 3.1). These
results suggest that TWN hubs are informative of splicing regulation, and
uncharacterized TE-IR hub genes in a TWN are good candidates for regulatory
effects on isoform abundance.
Co-regulation of expression and isoform ratios reflect biologi-
cal pathways
Genes with similar function or that participate in the same pathway often
have correlated patterns of gene expression (Hormozdiari et al., 2015; Khatri
et al., 2012; Prieto et al., 2008; Roider et al., 2009). In the GTEx TWNs, we
observed enrichment of edges between transcription factors and known target
genes (Figure 3.8A). We also observed greater enrichment of closely connected
genes for Reactome (Fabregat et al., 2016) and KEGG (Kanehisa et al., 2016)
pathways as compared with permuted networks (95 − 180 Reactome, and
39 − 82 KEGG pathways enriched per tissue at Bonferroni corrected p ≤ 0.05;
Wilcoxon rank-sum test; Figure 3.8B).
Patterns of correlation among relative isoform abundances are not well-
studied, and it has not been established whether the regulation of splicing
is coordinated across functionally related genes. Initial studies have iden-
tified such correlation in particular tissues (Iancu et al., 2015) and specific
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Rank Hub gene #Tissues Evidence
1 TMEM160 16
2 RBM14 15 Nuclear receptor coactivator that interacts with NCOA6 to
regulate splicing in a promoter-dependent manner. (Auboeuf,
Dowhan, Li, Larkin, Ko, Berget, & O’Malley, 2004; Auboeuf,
Hönig, Berget, & O’Malley, 2002; Sui, Yang, Xiong, Zhang,
Blanchard, Peiper, Dynan, Tuan, & Ko, 2007)
3 ZMAT1 16
4 PPP1R10 15 Mass spectrometry analysis suggests its involvement in pre-





8 SRRM2 15 Helps forming large splicing enhancing complexes (Chen &
Manley, 2009). A mutation in SRRM2 predisposes papillary
thyroid carcinoma by changing alternative splicing (Tomsic
et al., 2015).
9 SRSF11 14 A known serine/arginine-rich splicing factor (Wu, Kar, Kuo,
Yu, & Havlioglu, 2006; Zhang & Wu, 1996)
10 ZNF692 15
11 ARGLU1 16 Arginine/glutamate rich gene modulates splicing affecting
neurodevelopmental defects (Magomedova et al., 2016).
12 PPRC1 16 Encodes protein similar to PPARGC1 that regulates multiple
splicing events (Martínez-Redondo et al., 2016).
13 LUC7L3 15 Regulates splice-site selection (Zhou et al., 2008) and affects
cardiac sodium channel splicing regulation. (Gao et al., 2013)
14 DUSP1 16
15 FOSL2 16
16 XPO1 16 Interacts with TBX3 (Kulisz & Simon, 2008) that regulates
alternative splicing in vivo (mouse). (Kumar P. et al., 2014)
17 PNISR 15 Interacts with PNN, a suggested splicing regulator, and colo-
calizes with SRrp300, a known component of the splicing
machinery (Zimowska et al., 2003).
18 PNN 12 Likely to be involved in RNA metabolism including splicing
(Li et al., 2003)
19 PTMS 12 Involved in RNA synthesis processing (Vareli et al., 2000).
20 CCDC85B 15
Table 3.1: Top 20 cross-tissue TE-IR hubs. (Rank) Rank-product rank of the gene;
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Figure 3.8: Pathway enrichment in TWNs. Tissue colors are matched with tissue
names in Figure 3.3. A) Per-tissue, TF-Target enrichment among edges connected
by two TE nodes. B) Per-tissue, the number of Reactome pathways enriched among
connected components / total number of tested pathways for that tissue, considering
only total expression nodes. C-E) Enrichment for shared Reactome pathway annota-
tion among gene pairs connected by edges between two TE nodes (C), two IR nodes
(D), and a TE and an IR node (E).
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processes (Dai et al., 2012). To extend this, we evaluated each TWN for en-
richment of edges between functionally related genes. For all 16 tissues, the
TWNs demonstrated significant abundance of edges between isoform ratios
of two distinct genes that participate in the same Reactome pathway (all tis-
sues significant at BH corrected p ≤ 0.05; median p ≤ 10−14; Figure 3.8D).
Similarly, TE-IR edges were enriched for pairs of genes that participate in
the same pathway (median p ≤ 10−5; Figure 3.8E). As expected, we also
observed shared-pathway enrichment for nodes connected by TE-TE edges
(Figure 3.8C). The patterns of functional enrichment were stronger among
pairs of TE nodes, which may be due to more accurate quantification of total
expression versus isoform ratios from RNA-seq data, functional annotations
derived from gene expression studies, or tighter co-regulation of transcription
than splicing among functionally related genes. Leveraging the co-regulation
of splicing among functionally related genes, TWNs can be used to predict
gene function (Warde-Farley et al., 2010) based on a more comprehensive
understanding of co-regulation including regulation of splicing.
3.3.3 Comparison between TWNs reveals per-tissue hub genes
We evaluated the overall similarity of the TWNs between tissues. We tested
concordance of hubs between each pair of tissues using Kendall’s rank cor-
relation computed over genes ordered by degree centrality (Figure 3.9). We
observed greater than random levels of similarity between most tissues for
all hub types (median p ≤ 1.0 × 10−5 for each hub type), and functionally
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Figure 3.9: TWN Hub concordance. Heatmaps show Kendall’s correlation coeffi-
cients between tissue pairs using ranking of TE-TE (A), TE-IR (B), IR-TE (C), and
IR-IR(D) hubs. Tissue clustering dendrograms are shown at the left side of heatmaps.
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tissues were grouped together for each hub type, and were found to be similar
to esophagus – mucosa, which contains primarily epithelial tissue (Squier &
Kremer, 2001). Skeletal muscle and heart – left ventricle grouped together, and
breast – mammary was similar to the two adipose tissues, reflecting shared
adipose cell type composition. While these results may be influenced by over-
lapping donors, they provide evidence that splicing is more similar in tissues
with shared cell type compositions (Ong & Corces, 2011; Qian et al., 2005; The
GTEx Consortium, 2017).
To identify candidate tissue-specific regulatory genes, we evaluated TE-IR
hubs that had a high rank in related tissues, but a low rank among unrelated
tissues. Several of the top ranked tissue-specific hubs were genes with ev-
idence of known tissue-specific function or relevance. In the tissue group
including breast – mammary and the two adipose tissues, the top tissue-specific
TE-IR hub was TTC36, a gene highly expressed in breast cancer (Liu et al.,
2008). The second ranked hub gene for the tissue group including skeletal mus-
cle and heart – left ventricle was LMOD2, which was observed to be abundantly
expressed in both tissues, and has been reported to regulate the thin filament
length in muscles affecting cardiomyopathy in mice (Li et al., 2016b; Pappas
et al., 2015).
We evaluated the tissue-specificity of our identified hub genes. To do this,
we computed the fraction of top 100 TWN hubs of each tissue that did not
appear in the list of top 500 TWN-hubs of any other tissue. We found that 8–
43%, 11–39%, 0–24%, and 0–20% of our top 100 TE-TE, TE-IR, IR-TE, and IR-IR
hubs, respectively, were uniquely identified in a single tissue. TE hubs (TE-TE
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and TE-IR hubs) were more likely to be tissue-specific than matched IR hubs
(IR-TE and IR-IR hubs; one-sided Wilcoxon signed rank test, p ≤ 4.13 × 10−7).
Tissue-specific hub proportions were not significantly different between TE-TE
and TE-IR hubs (two-sided Wilcoxon signed rank test, p ≤ 0.52). Many of the
hub genes were differentially expressed across tissues (Table A.3).
An average of 69.87% of tissue-specific TWN edges connected nodes where
at least one node was differentially expressed between the tissue of interest
and all other tissues. For 6.9% of tissue-specific edges, at least one node was
not included in a TWN for any other tissue because of low expression or
other filters. However, for the remaining 23.22% of tissue-specific edges, both
nodes were expressed in other tissues and included in other networks, so the
tissue-specificity of edges is not exclusively due to expression levels.
3.3.4 Tissue-specific networks identify gene co-expression pat-
terns unique to tissues
Transcriptome-wide networks (TWNs) reflect full gene network without distin-
guishing between tissue-shared and tissue-specific relationships. To directly
assess the tissue-specificity of co-expression relationships, we built tissue-
specific networks (TSNs) by considering all GTEx samples across 50 tissues
simultaneously, decomposing the contributions to gene expression level vari-
ation into signals shared across tissues and those specific to single tissues.
Taking genes that had non-zero counts in at least 10% samples in each and
every tissue, we identified TSNs for 26 GTEx tissues. Here, we limited net-
work nodes to total gene expression for simplicity. Across the 26 TSNs, the






























































Figure 3.10: TSN edges were supported by TWNs and ARACNE networks. We
selected edges from a TSN where both genes connected by an edge were jointly
included in the matched TWN and at least another unmatched TWN. Then we tested
if the path length between the nodes of a selected edge was significantly smaller in the
matched TWN than in an unmatched TWN using one-sided Wilcoxon signed-rank
test. A) Histogram of node distance differences for artery-aorta. As expected, most of
the differences were negative, meaning that the nodes connected in artery-aorta TSN
were closer to each other in artery-aorta TWN compared to other tissues’ TWNs. B)
BH corrected p-values for each tissue. Y-axis has been truncated to have a maximum
value of 50. Note: a small number of edges (≤ 3) were selected for lung, skeletal muscle,
and esophagus–muscularis, and p-values for these tissues were not reported. C) BH
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Figure 3.11: Association of local genetic variants with distant network neighbors.
(A) Enrichment of association between rs113305055, a genetic variant near a cross-
tissue TWN hub TMEM160, with all isoform ratios genome-wide in artery – tibial. (B)
Enrichment of associations between local genetic variants (either the top cis-eVariant
or any variant within 20 kb) of each gene, and network neighbors in the TSNs. (C)
Enrichment of association between rs115419420, a genetic variant local to CRELD1,
with all isoform ratios in skeletal muscle.
was 24, and the average number of edges was 107. As expected, TSNs con-
tained a small subset of edges from full per-tissue TWNs, representing the
co-expression components that are tissue-specific rather than shared. How-
ever, the signal in the TSNs is still reflected within their matched TWNs for
the eight tissues where we reconstructed both networks (Figure 3.10).
3.3.5 Integration of networks with regulatory genetic variants
Both TWNs and TSNs were estimated using gene expression data alone. How-
ever, the GTEx v6 data also include genotype information for each donor.
We intersected the edges detected by our networks with expression quantita-
tive trait locus (eQTL) association statistics to replicate specific network edges
through evidence of conditional associations with genetic variants across those
edges and to increase power to detect long range (trans) effects of genetic
variation on gene regulation.
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First, we demonstrated that, for both TWNs and TSNs, there was enrich-
ment for associations between the top cis-eVariant (the variant with lowest
p-value per gene with a significant cis-eQTL) for each gene and the expression
level or isoform ratio of its network neighbors based on QTL mapping in
the corresponding tissue (Figure 3.11). This provides evidence of a causal
relationship between connected genes. For TWNs, evaluating TE nodes with
an IR neighbor, we found evidence for 61 trans (i.e., inter-chromosomal) asso-
ciations and 86 intra-chromosomal associations tested between a cis-eVariant
for the TE gene and the IR of the neighboring node (FDR ≤ 0.05). Our top
two associations were between two variants, rs113305055 in artery – tibial and
rs59153288 in breast – mammary (both near TMEM160), with isoform ratios of
CST3 (p ≤ 9.3 × 10−8, and p ≤ 4.0 × 10−7, respectively). TMEM160 is the top
cross-tissue hub in our TWNs with many IR neighbors (Table 3.1). Thus, we
tested for association of these variants with all isoform ratios genome-wide
and observed a substantial enrichment of low p-values in numerous tissues
(Figure 3.11A; Figure A.1). In the TSNs, we identified five cis-eVariants across
five tissues associated with six different trans-eGenes through six unique cis-
eGene targets, one of which was intra-chromosomal (FDR ≤ 0.2; Table A.5).
We also observed enrichment for low p-values over the tests corresponding to
each network edge (Figure 3.11B).
We also performed a restricted test to identify novel trans-QTLs, without
relying on the cis-eQTL signal from the same data, to avoid discoveries driven
by potentially spurious correlations among expression levels. From the TWNs,
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Variant trans-eTranscript trans-sGene Local gene P-value FDR Tissue
rs6122466 ENST00000496440.1 CEP350 PPDP 9.08 × 10−7 0.09 Adipose – Visceral
rs397828484 ENST00000528430.1 PPP1R16A NMRK2 1.66 × 10−6 0.10 Muscle – Skeletal
rs7668429 ENST00000340875.5 MEF2D CLOCK 4.81 × 10−6 0.10 Muscle – Skeletal
rs7980880 ENST00000409273.1 XIRP2 CALCOCO1 9.91 × 10−6 0.11 Muscle – Skeletal
rs56359342 ENST00000396435.3 IQSEC2 CRAMP1L 1.43 × 10−5 0.14 Muscle – Skeletal
rs115419420 ENST00000531388.1 CARNS1 CRELD1 2.18 × 10−5 0.19 Muscle – Skeletal
Table 3.2: Trans-sQTLs detected based on TWN hubs. (Variant) The most significant
variant per trans-sGene listed; P-value and FDR for association between the variant
and the trans-sGene listed; local gene target listed for reference.
we sought to identify trans-splicing QTLs (sQTLs) based on TE-IR hub genes,
using the top 500 hubs by degree centrality. We tested every SNP within
20 kb of the TE hub-gene’s transcription start site (TSS) for association with
isoform ratios of each neighbor in the TWN. Using this approach, we identified
58 trans-sQTLs corresponding to six unique genes (sGenes) at FDR ≤ 0.2
(Table 3.2). For example, we identified a trans-sQTL association in skeletal
muscle between rs115419420 and CARNS1 (p ≤ 2.18 × 10−5) that is supported
by a cis association with the TE-IR hub CRELD1. This variant also showed
enrichment for low p-values with numerous isoform ratios genome-wide
(Figure 3.11C). In the TSNs, we identified 14 trans-eQTLs using variants
within 20 kb of each gene and testing for association with the neighbors
of those genes in the gene expression data of the same tissue (FDR ≤ 0.2;
Table A.6). All of these associations were inter-chromosomal. Overall, we saw
an enrichment of p-values for association between genetic variants local to a
gene and the gene’s neighbors in each network (Figure 3.11B).
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3.4 Discussion
We reconstructed co-expression networks that capture novel regulatory re-
lationships in diverse human tissues using large-scale RNA-seq data from
the GTEx project. First, we specified an approach for integrating both total
expression and relative isoform ratios in a single sparse Transcriptome-Wide
Network (TWN). Splicing is a critical process in a number of tissue- and
disease-specific processes and pathways (D’Souza et al., 1999; Ghigna et al.,
2008; Glatz et al., 2006; Hutton et al., 1998), but, critically, isoform ratios have
not been included in co-expression network analysis to allow the study of
splicing regulation. We estimated TWNs from sixteen tissues and demon-
strated that hubs in TWNs are strongly enriched for genes involved in RNA
binding and RNA splicing. We found that, across tissues, the top hub genes
with isoform ratio neighbors included many genes with known impact on
splicing such as RBM14, a hub in all 16 tissues with TWNs. We identified a
number of novel shared and tissue-specific candidate regulators of alternative
splicing. While TWNs demonstrated clear enrichment for capturing desired
regulatory relationships, care should be taken in interpreting individual edges
and network relationships, as false positives may still arise due to confound-
ing technical and biological factors, and from estimating large networks based
on limited sample sizes. However, as more large-scale RNA-seq studies and
better transcript quantification tools become available, TWNs will continue to
be a useful and extensible framework for analyzing diverse types of regulatory
relationships in disease, longitudinal, and context-specific studies.
Next, we estimated Tissue-Specific Networks (TSNs) for 26 single tissues.
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These networks represent co-expression relationships unique to individual
tissues.
Finally, we replicated edges in our networks using integration of genetic
variation, and we identified 20 novel trans-QTLs affecting both expression
and splicing. Together, our results provide the most comprehensive map
of gene regulation, splicing, and co-expression in the largest set of tissues
available to date. These networks will provide a basis for interpreting the
transcriptome-wide effects of genetic variation, differential expression and
splicing in complex disease, and the impact of diverse regulatory genes in the
human genome.
3.5 Data and code availability
Software is publicly available on GitHub: https://github.com/battle-lab/




Inference and evaluation of
co-expression networks
In the previous chapter, we used graphical lasso (Friedman et al., 2008) to study
the regulation of transcription and splicing. In this chapter, we focus on a
novel method to infer co-expression networks from gene expression profiles.
The method is widely applicable to study the regulation of transcription. Our
main contributions are listed below.
• We developed a novel method, SPICE, to reconstruct gene networks from
gene expression profiles that prioritizes potential direct gene regulatory
relationships.
• We also formulated a comprehensive set of evaluation metrics that use
real biological data to compare network reconstruction methods.
• Using RNA-sequencing data of 49 tissues in humans from the Genotype-
Tissue Expression (GTEx) consortium, we show that SPICE performs
better than currently available methods in terms of most of our evalua-
tion metrics.
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This work has not yet been published.
4.1 Introduction
Gene co-expression networks (GCNs) capture the correlation between pairs
of genes based on their expression profiles and can be used to infer gene
regulatory relationships. However, the accuracy of GCNs remains low, es-
pecially for large complex networks (Chen & Mar, 2018; Guo et al., 2017;
Marbach et al., 2012). Researchers need high-quality methods to estimate
gene co-expression networks. Particularly, it is important to identify direct
relationships between genes, as opposed to indirect associations via other
genes, as direct relationships better illuminate functional mechanisms. To
prioritize candidate direct regulatory relationships, we developed a novel
method, SPICE, to reconstruct a gene network from gene expression profiles.
SPICE utilizes maximum spanning trees to identify candidate direct edges in
the network.
To evaluate network inference methods, researchers commonly use simu-
lated data. However, biological data are generally more complex and noisier
than simulated data. Methods that work well on simulated data may not
perform similarly on real-world data (Marbach et al., 2012). A common ap-
proach in real-world network evaluation is to measure the area under the
precision-recall curve (AUPR) of the learned network edges compared to a
ground truth knowledge-base of known gene interactions. However, AUPR
only captures a certain aspect of network fidelity to ground truth. Given our
current knowledge of gene regulation is generally incomplete, noisy, and not
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context-specific, network evaluation based on a single aspect of the current
knowledge-base may not be reliable. To address this issue, we developed
several evaluation metrics that capture diverse aspects of a gene network: i)
does the network preserve the ranking of edges? ii) are the top hits precise? iii)
how accurately does the network identify the hub genes? iv) do the connected
genes share the same pathway? v) do the genes in a pathway cluster together?
vi) how well can the network help detect trans-regulatory genetic variants?
vii) how well can the network distinguish between direct and indirect interac-
tion? These metrics enable us to benchmark network reconstruction methods
comprehensively.
Using both simulated data and RNA-sequencing data of 49 tissues in
humans from the GTEx consortium, we show that SPICE performs better than
currently available methods in terms of most of our evaluation metrics. For
example, based on protein-protein interactions from STRING (Szklarczyk et al.,
2019), SPICE improves AUPR on average by 8.3%, rank preservation by 56%,
and precision by 19.3%, relative to the best currently available methods. Based
on the hallmark gene sets for humans in the molecular signature database
(MSigDB) (Liberzon et al., 2005), SPICE improves pathway sharing by 14.7%
relative to the best performance among currently available methods.
4.2 Methods
4.2.1 SPICE
SPICE is a computation framework to reconstruct a co-expression network





























D .6 .1 .2
E .9 .4 .5 .3




10 5.5 7 3.5




0 .56 .44 .67
Pairwise 
Association, 𝐴(")
= 1 − 𝐷(")/max(𝐷("))




D .4 .9 .8
E .3 .6 .65 .7




D 8 1 2
E 9 6.5 5 4




D 8.1 1 2.1
E 9.5 5.9 5.8 3.7
𝑅$
(") = 𝑟𝑎𝑛𝑘(𝐶("))𝐶(") = |𝑐𝑜𝑟(𝑋("))|










D .15 1 .76




























Figure 4.1: SPICE framework. SPICE is an ensemble learning algorithm to recon-
struct a co-expression network (W) from gene expression profiles (X). In each iteration
(t), it first computes gene-gene correlations (C(t)) from sub-sampled expressions (X(t)).




1 directly ranks C
(t), and R(t)2
ranks the same matrix via a maximum spanning tree, prioritizing potential direct reg-
ulatory relationships. Rankings from all iterations are aggregated using rank-product.
Finally, SPICE assigns weights to each edge based on the rank-product to generate
the co-expression network matrix (W).
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aggregates rankings of edges between genes over multiple iterations. Given
gene expression profiles of s samples across g genes (X ∈ Rg×n), SPICE
estimates a co-expression matrix W ∈ Rg×g representing relative rankings of
edges (or interactions) between genes (Figure 4.1). Here, we assume that the
expression values in X are processed, normalized, and already adjusted for
confounding effects (Parsana et al., 2019; Stegle et al., 2012).
In each iteration, SPICE samples the given gene expression profiles, com-
putes a gene-gene correlation matrix, and generates two ranking matrices.
Formally, in t-th iteration (1 ≤ t ≤ T), we generate a sub-sampled gene ex-
pression matrix X(t) by randomly selecting a fraction of samples (default 80%)
and genes (default 80%) from X using uniform sampling without replacement.
Without loss of generality, let, X(t) preserves the order of the genes in X with
NA’s for genes not selected in t-th iteration. Then, we compute a pairwise





Here, X(t)i represents the expression of i-th gene across all selected samples. By
default, we use Pearson correlation coefficient as cor function. Alternatively,
normalized mutual information or Spearman correlation coefficient could be
used. We assume cor function produces a symmetric correlation matrix where
each element ∈ [0, 1].
From the correlation matrix C(t), we generate two symmetric g × g ranking
matrices, R(t)1 and R
(t)
2 . Computation of R
(t)
1 is straight-forward: the lower
triangle (excluding the diagonal) of R(t)1 contains the ranking of the lower
triangle of C(t). The highest value is given a rank of 1, the 2nd highest value is
given a rank of 2, and so on. In case of ties, the average ranking is used. The
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diagonal elements are ignore (set to NA) and the off-diagonals are symmetric
i.e., the (i, j)-th entry in the upper triangle of the ranking matrix is equal to
the (j, i)-th element in the lower triangle.
R(t)2 is computed following a series of steps described below.
1. A maximum spanning tree (MST) is generated from the undirected
graph corresponding to the correlation matrix C(t), where the weight of
each edge between gene i and gene j is C(t)ij .
2. The weight of each edge in the MST is converted to a distance measure
by subtracting the current weight from 1.
3. A pairwise distance matrix D(t) is computed where D(t)ij = shortest dis-
tance between gene i and gene j in the MST. Assuming the edges in
the MST represent potential direct regulatory relationships, the distance
between directly connected genes would stay the same, but the distance
between indirectly connected genes would increase.
4. D(t) is converted to a pairwise association matrix, A(t) = 1−D(t)/max(D(t)).
5. R(t)2 contains the ranking of A
(t) computed in the same way as described
in the previous paragraph.




2 , . . . , R
(T)
2 ) are aggre-






R(t)2ij . An edge between gene i and gene j will be ranked
at the top (i.e., Rij will be small) when it is ranked at the top in all or most
iterations.
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While R provides the ranking of all edges, it does not provide the relative
weights. To provide relative weights for each edge, we convert the rankings
to quantiles of a half-normal distribution (positive values only), standardize
by dividing by the quantile of the maximum possible rank, rmax = (g2), and
raise it to the power β. Formally, the weight of the edge between gene i and
gene j, Wij =
[︁ q1/2(1−Rij/rmax)
q1/2(1−1/rmax)
]︁β, where q1/2(p) represents the quantile of an
half-normal distribution at probability p, and β is selected in such a way that
the network approximately follows a scale-free topology (similar to Weighted
Gene Co-expression Network Analysis (WGCNA) (Langfelder & Horvath,
2008; Zhang & Horvath, 2005)).
The weight matrix W represents the co-expression network. We should
note that the weights in W do not represent any physical or statistical property,
rather they represent a relative ranking of edges.
4.2.2 Evaluation metrics
To evaluate co-expression network reconstruction methods, we developed a
comprehensive set of evaluation metrics using real data (Figure 4.2). Contrary
to evaluation using simulated data, our evaluation metrics provide an assess-
ment of how well each method performs in practice. These metrics build on
the current knowledge-base of transcription regulation and can be applied to
diverse contexts to further our understanding.
Our evaluation framework uses four types of inputs: i) an estimated net-


































G1 G2 3.0 0.9 1
G1 G3 0 0 0
… … … … …
















































G1 6.5 2.1 1.00
G2 4.0 1.3 0.62
… … … …
G6 4.0 0.8 0.38
2. Spearman r
(between E and K)















































Inputs Metric computation steps Metrics
1. Interaction AUPR






















F Ψ( = {𝑒𝑑𝑔𝑒)$(𝐺*, 𝐺+ )|𝑑)% 𝐺*, 𝐺+ = 𝑎}

































Figure 4.2: Evaluation metric computation framework. A) The framework requires
four types of inputs: an estimated network (NE), a known network (NK), a pathway
database D, and eQTL statistics (Q). B) Each row in the table contains information
about an edge (interaction) between two genes: the weight of the edge in NE (E),
the weight of the edge in NK (K), and whether both genes share some pathway in
D (S). Interaction AUPR is the area under the precision-recall (PR) curve computed
using K as the ground truth probability and E as the classification score. Spearman r
between E and K evaluates rank preservation. Precision is defined as the fraction of
high-confidence (K ≥ threshold) edges in n top-weighted edges. Shared pathway AUPR
is the area under the PR curve using S as the ground truth and E as the classification
score. C) Each row in the table represents the centrality of a gene. Estimated centrality
(CE) and known centrality (CK) of a gene are defined as the sum of weights of edges
connected with the gene in NE and NK, respectively. Hub AUPR is the area under the
PR curve using normalized known centrality (CN) as the ground truth probability
and CE as the classification score. D) P-value of each pathway in D is the probability
that the observed pathway score is greater than or equal to that of a random gene set
of the same size. We compute the total number of enriched pathways in D at FDR
≤ 0.05. E) For each top-weighted edge in NE, we test the variants nearby one gene for
trans-association with the other gene and compute the total number of trans-eGenes
using eQTL statistics Q. F) Rankdiff is the difference between average ranks of edges
in NE where the corresponding genes have certain distances in NK.
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statistics (Q) (Figure 4.2A). The estimated network (NE) is a weighted undi-
rected graph of genes, where the weight of each edge indicates the confidence
of the edge i.e., how the method judges that the interaction between the genes
is true.
The known network (NK) is also a weighted undirected graph where the
weights are within [0,1] range representing the probability that the corre-
sponding genes interact with each other. Protein-protein interaction (PPI)
networks such as STRING (Szklarczyk et al., 2019) and InWeb_IM (Li et al.,
2016c) annotate each edge with such a score. Other binary PPI networks or
gene-gene networks such as HuRI (Luck et al., 2020) can also be used with
the probability score of either 0 or 1. STRING (Search Tool for the Retrieval
of Interacting Genes/Proteins) annotates a large number of PPIs with con-
fidence scores based on experimental data, literature and database mining,
and genomic context analysis. Importantly, STRING is well-maintained and
regularly updated, making it a good candidate for network evaluation. We
use STRING as the default choice of the known network.
Pathway databases are another important resource our framework uses.
Conceptually, each pathway is a set of functionally relevant genes. A pathway
database contains information about many pathways (or gene sets). KEGG
(Kanehisa et al., 2016), REACTOME (Fabregat et al., 2016), BIOCARTA, Gene
Ontology (Ashburner et al., 2000), etc. are some of the popular pathway
databases. Molecular signature database (MSigDB) (Liberzon et al., 2005)
contains a collection of pathway databases. Notably, MSigDB curates a list of
50 hallmark gene sets from multiple sources using a combination of automated
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approaches and expert curation. These gene sets with reduced noise and
redundancy represent well-defined biological states or processes and display
coherent expression. In this work, we use MSigDB Hallmark gene sets as the
pathway database unless stated otherwise.
Each row in the eQTL statistics table (Q) contains information about the
test between a variant and a gene. In this project, we use eQTL statistics
computed using data from the GTEx consortium (The GTEx Consortium,
2020).
Our evaluation framework defines eight metrics based on the above inputs.
1. Interaction AUPR. Detecting gene-gene interactions is a primary tar-
get of a gene co-expression network. Interaction AUPR measures how
well an estimated network (NE) captures the known interactions in NK.
Considering each edge weight of NK as the ground truth probability,
we compute the weighted area under the precision-recall curve (AUPR)
of the estimated edge weights of NE, which we call interaction AUPR
(Figure 4.2B). The weighted AUPR is computed using the pr.curve() func-
tion in the PRROC R package. For this metric and a couple of other
metrics defined later, we used the precision-recall curve, not the receiver
operating characteristic (ROC) curve, due to the imbalance observed in
the ground truth corresponding to a small number of positive examples
in contrast to the large number of negative examples. This metric is
commonly used to evaluate gene regulatory network reconstruction
methods (Chen & Mar, 2018; Guo et al., 2017).
2. Spearman ρ. Spearman ρ is defined as the Spearman rank correlation
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coefficient between the estimated weights and the known weights of all
possible edges (Figure 4.2B). It assesses whether the estimated network
preserves the ranking of the known network.
3. Precision. Top predictions from a network are often used in downstream
analysis or follow-up studies (Ideker et al., 2001). Thus it is important for
a network reconstruction method that its top predictions are true. The
fraction of known high-confidence edges in n top-weighted edges from
the estimated network is defined as precision. In the case of STRING, we
considered edges with a score of 0.7 or higher as known high-confidence
edges. We chose n to be the total number of known high-confidence
edges between the genes used to reconstruct the network.
4. Hub AUPR. Hub genes play an important role in gene regulation (Saha
et al., 2017; Seo et al., 2009; Seoane et al., 2019). To assess how the
estimated network (NE) captures known hubs in NK, we first compute
the estimated centrality (CE) and the known centrality (CK) defined as
the sum of weights of edges the gene is connected to in NE and NK,
respectively (Figure 4.2C). Then we divide CK by max(CK) to get the
normalized known centrality (CN). Using CN as the probability that
the hub is true, we compute Hub AUPR as the weighted area under the
precision-recall curve of CE.
5. Shared pathway AUPR. Genes in a biological pathway generally have
similar functions or share transcriptional regulatory programs. For
evaluation based on this characteristic, we first define a random variable
S indicating whether both genes corresponding to a given edge are
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present in some pathway in D (Figure 4.2B). Then, considering S as
an indicator of ground truth, we compute the weighted AUPR of the
estimated edge weights (E), which we call shared pathway AUPR.
6. Pathway enrichment. Genes in a pathway are expected to cluster to-
gether in a network because of their functional similarity. If gene pairs
from a given pathway are closer in the estimated network (NE) than
expected by chance, we state that the pathway is enriched in the network.
Formally, we define a score for each pathway as the sum of absolute
weights of edges between all possible gene pairs in the pathway. To get
the null distribution of scores, we create 10,000 random gene sets with
the same number of randomly selected genes, compute their scores, and
fit a normal distribution. The enrichment p-value of the pathway is com-
puted as 1 − cd f (pathway score), where cd f refers to the cumulative
distribution function. We use the total number of enriched pathways in
D at FDR ≤ 0.05 as an evaluation metric. In this work, we computed
the enrichment of a pathway only if at least 5 genes and at most 100
genes from the pathway were included in the input data for network
reconstruction.
7. Number of trans-eGenes. Detecting trans (inter-chromosomal) expres-
sion quantitative trait loci (trans-eQTLs) is computationally challeng-
ing because of the high number of tests and the corresponding high
multiple test burden. Given that many trans-eQTLs are mediated by
cis-associations (The GTEx Consortium, 2017, 2020), we can use rela-
tionships in a gene co-expression network to select a small number of
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variant-gene pairs to test and thus increase the statistical power to detect
trans-eQTLs (Saha et al., 2017). For each of the 10,000 top-weighted
edges in the estimated network, we test genetic variants located within
1 Mb of one gene to the expression of the other gene. The total number
of unique trans-eGenes (genes with at least one trans-eQTL) detected
following this approach (FDR ≤ 0.05) quantifies the network’s ability to
help detect trans-eQTLs. We used the linear model in matrix-eQTL to
call the trans-eQTLs from GTEx data.
8. Rank difference. It is expected that the direct interactions would be
ranked higher (lower absolute value) than indirect interactions. To
measure this quality, we first compute the mean rank of edges in the
estimated network (NE), where each edge corresponds to two genes with
a given geodesic distance in the known network (NK). Let, R1¯ represents
the mean rank of edges in NE where the genes are directly connected in
NK, R2¯ represents edges where the genes are 2-hop away from each other
in NK, and so on. Then we compute the difference between the mean
ranks of two given geodesic distances a and b as Rankdiffa−b = Ra¯ − Rb¯ .
As an illustrative examples, a high positive Rankdiff2−1 would mean that
the network well distinguishes the direct interactions between pairs of
genes from indirect interactions via another gene.
4.2.3 Implementation of gene co-expression networks
We implemented SPICE and benchmarked its performance against popular
network reconstruction frameworks
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SPICE. We implemented the SPICE method as an R package. The code is
publicly available on GitHub. We used the spice() function in the package with
default configurations as described in section 4.2.1.
WGCNA. We reconstruct a signed weighted gene co-expression network (Zhang
& Horvath, 2005) as ((1 + cor)/2)β where cor represents Pearson correla-
tion between all gene pairs, and β is selected to make the network approx-
imately scale-free using the pickSoftThreshold() function in the WGCNA R
package (Langfelder & Horvath, 2008). We select the smallest β ∈ { 1, 2, 3, 4, 5,
6, 7, 8, 9, 10, 12, 14, 16, 18, 20 } with a scale-free topology fitting index (Zhang
& Horvath, 2005) R2 ≥ 0.8. If no β has R2 ≥ 0.8, we select the β with the
highest R2.
Graphical Lasso. We reconstruct a graphical lasso network (Friedman et al.,
2008) by estimating a sparse inverse covariance matrix with L1-regularization
using the glasso() function in the glasso R package. We do not penalize the
diagonals and use a maximum of 1000 iterations. To select the regularization
parameter (ρ), we split the gene expression matrix into two parts: a training
data set with randomly selected 80% samples, and a validation data set with
the rest 20% samples. For each ρ ∈ {0.05, 0.1, 0.15, ..., 0.5}, we estimate the
inverse covariance matrix using the training data set, and then compute the
held-out likelihood using the validation data set. We select the regularization
parameter ρ that produced the highest held-out likelihood and call the glasso()
function using all the samples. In this chapter, the graphical lasso may be
abbreviated as GLasso.
MRNET and MRNETB. We first build a mutual information matrix using the
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build.mim() function with estimator = “pearson” in the minet R package, and
then call the mrnet() and mrnetb() function in the same package using the
mutual information matrix to get MRNET (Meyer et al., 2007) and MRNETB
(Meyer et al., 2010) networks, respectively.
GENIE3. We infer the GENIE3 network (Huynh-Thu et al., 2010) using the
GENIE3() function in GENIE3 R package. For each target gene, we use an
ensemble of 1000 trees using the Extra-Trees method.
ARACNE. To get an ARACNE network (Margolin et al., 2006), we first build
a mutual information matrix using the build.mim() function with estimator =
“pearson” and disc = “equal f req” in the minet R package, and then call the
aracne() function with eps = 0.1 in the same package using the mutual infor-
mation matrix.
CLR. We inferred a CLR network (Faith et al., 2007) by first building a mutual
information matrix using the build.mim() function with estimator = “pearson”
and disc = “equal f req” in the minet R package, and then calling the clr()
function with default parameters.
Partial Correlation. We calculate the pairwise partial correlation coefficient
for each pair of genes given others using the pcor() function with method =
"spearman" in the ppcor R package and use it as a weight of the edge between
the genes.
Random network. For each pair of genes, we generate a random number
from a standard normal distribution and use its absolute value as the weight
of the edge between the genes. A random network serves as a baseline for
network reconstruction methods.
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4.2.4 Symmetric absolute weighted network
To ensure higher weights represent higher confidence, we take absolute edge
weights for each tissue and treat both positive and negative associations
equally. If any method (e.g., GENIE3) produces an asymmetric network, then
we convert it to a symmetric network by taking the maximum absolute value
of weights of edges in two directions between each pair of genes.
4.2.5 Simulation
We simulated 5 data sets from multivariate normal distributions using the huge
R package. Each data set had 200 samples. Each data set had an underlying
network of 1,000 nodes (genes) and approximately 5,000 edges selected at a
probability of 1%.
4.2.6 GTEx (v8) data
We downloaded fully processed, filtered, and normalized gene expression ma-
trices for 49 tissue from the GTEx portal (http://gtexportal.org, GTEx_Analysis-
_v8_eQTL_expression_matrices.tar). Full details of data collection and process-
ing are available in a paper by The GTEx Consortium (The GTEx Consortium,
2020). Briefly, RNA sequencing was performed using the Illumina TruSeqTM
RNA sample preparation protocol. Sequencing was performed using HiSeq
2000 or 2500 to generate 76bp paired-end reads (median coverage 83M total
reads). Reads were aligned to the human reference genome GRCh38/hg38
(excluding ALT, HLA, and decoy contigs) with STAR v2.5.3a. Gene-level read
counts and TPM values were produced with RNA-SeQC v1.1.9 using the
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“-strictMode” flag in RNA-SeQC. For each tissue, i) genes with TPM > 0.1
in at least 20% of samples and read counts ≥ 6 in at least 20% of samples
were selected, ii) gene expressions were normalized between samples using
TMM (Robinson & Oshlack, 2010), and iii) expression values of each gene
were normalized across samples using an inverse normal transform.
We also downloaded the covariates for each tissue from the GTEx portal
(GTEx_Analysis_v8_eQTL_covariates.tar.gz): 5 genotyping PCs, a set of co-
variates identified using the Probabilistic Estimation of Expression Residuals
(PEER) method (Stegle et al., 2012), sequencing platform, sequencing protocol,
and sex. We regressed out all available covariates from expressions for each
tissue.
In our analysis, we used protein-coding genes from chromosomes 1-22 and
X with unique HGNC gene symbols according to GENCODE v26 annotations.
If multiple genes overlapped in their co-ordinates, we selected one of them
with the highest variance. Finally, we selected the most variable 5000 genes
from each tissue for further analysis.
4.3 Results
4.3.1 Simulation study
To demonstrate that our method can capture known regulatory relationships,
we applied SPICE and current popular network inference methods on five
simulated data sets. Each data set was generated from a multivariate normal
distribution with a known underlying network structure of 1,000 genes and
approximately 5,000 edges. Every method performed better than the baseline
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Figure 4.3: Network evaluation using simulated data. Each plot shows the perfor-
mance of network inference methods (x-axis) in terms of an evaluation metric (y-axis,
name at the top). Each black dot represents a method’s performance using one of
the five data sets. The red dot and the red bar represent the mean and the standard
deviation of a method’s performance across five data sets.
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Figure 4.4: Evaluation of network inference methods. The performance of network
reconstruction methods (x-axis) in terms of each evaluation metric (y-axis, name at
the top). Each black dot represents a method’s performance using one of the 49 tissues
in GTEx. The red dot and the red bar represent the mean and the standard deviation
of a method’s performance across all tissues.
set by a random network (Figure 4.3). SPICE, along with WGCNA, MRNET,
MRNETB, ARACNE, GENIE3, and CLR, was among the top performers
to capture known regulatory relationships in terms of interaction AUPR,
precision, hub AUPR, and rank difference. Notably, both interaction AUPR
and precision were relatively low (0.35-0.45 and 0.38-0.45, respectively) even
for the top-performing methods, highlighting the difficulty to estimate a large
number of parameters from a relatively small number of samples.
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4.3.2 Networks from diverse human tissues
Real biological networks are generally more complex and noisier than simu-
lations. The underlying distribution of biological data is usually unknown.
Gene collinearity, imprecise expression measurement, confounding factors,
etc. further complicate the inference of biological networks.
To evaluate the performance of SPICE and other methods to estimate
biological networks, we downloaded RNA-sequencing data of 49 tissues in
humans from the Genotype-Tissue Expression (GTEx) consortium. After
quality control, data processing, and confounding factor correction, each
tissue had normalized gene expression of 5,000 highly variable autosomal
protein-coding genes across 73-706 individuals.
Before applying each method to this data set, we optimized the parameters
of each method using 1,500 genes across four tissues: Lung (515 samples),
Heart – Left Ventricle (386 samples), Pancreas (305 samples), and Brain –
Cerebellum (209 samples). We selected a parameter that resulted in a superior
performance among possible options. For example, we used Extra-Trees
(Geurts et al., 2006), instead of Random Forests, to build trees in GENIE3,
because Extra-Trees generally produced superior performance in terms of our
evaluation metrics. For the same reason, we estimated the mutual information
in MRNET and MRNETB from a normal distribution instead of the empirical
distribution.
Once the optimum parameters are selected, we applied SPICE and other
methods to build gene co-expression networks for each tissue. Then, we












































Figure 4.5: Rank difference (left) and the total number of trans-eGenes fromm
all 49 tissues (right). ’2-1’, ’3-2’, and ’4-3’ in the left plot represents Rankdiff2−1,
Rankdiff3−2, and Rankdiff4−3, respectively.
from STRING, the pathway database from MSigDB Hallmark gene sets, and
eQTL statistics from GTEx. Similar to the simulation analysis, all the methods
performed, on average, better than the baseline set by the random network in
terms of each metric (Figure 4.4). On average, SPICE was the best-performing
method according to interaction AUPR, Spearman ρ, precision, and shared
pathway AUPR. It improves interaction AUPR on average by 8.3%, rank
preservation by 56%, precision by 19.3%, and shared pathway AUPR by 14.8%
relative to the current best method WGCNA.
SPICE performed comparably to the top method in terms of hub AUPR,
and rank difference between the 1st and 2nd-degree edges. Notably, SPICE
had larger rank differences between higher-degree edges compared to other
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methods (Figure 4.5). The performance was slightly low in terms of the num-
ber of enriched pathways (Figure 4.4). It may happen because the pathway
enrichment, along with hub AUPR, depends on the absolute weights of edges,
and SPICE computes the ranking of edges rather than absolute weights. For ex-
ample, changing the power (β) to compute the final weight matrix, which does
not change the edge ranking, may change the number of enriched pathways.
In contrast, interaction AUPR, Spearman ρ, precision, and shared pathway
AUPR depend on edge ranking, and SPICE performs well according to these
metrics.
The number of trans-eGenes was small and highly-variable across tissues
(Figure 4.4). It is not surprising owing to the difficulty of identifying trans-
eQTLs. The full analysis of GTEx (v8) found only 121 protein-coding eGenes
corresponding to 20 out of 49 tissues (The GTEx Consortium, 2020). So, instead
of looking at the number of trans-eGenes from each tissue, we considered the
total number of trans-eGenes from all tissues (Figure 4.5). Partial correlation
detected the highest 98 trans-eGenes, and graphical lasso, which estimates
an inverse covariance matrix proportional to partial correlation, found the
second-highest number of 84 trans-eGenes. In comparison, SPICE found a
total of 71 trans-eGenes comparable to other methods.
The evaluation of the network reconstruction methods was robust to the
change in ground-truth resources. We tried alternative sources for the known
interaction network (NK): i) Experiment: each interaction score was derived
only from experimental evidence as categorized by STRING (Szklarczyk et al.,
2019), ii) InWeb_IM: The scored human protein-protein interaction network
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Spearman r (Experiment) Spearman r (InWeb_IM)
Rankdiff 2−1 (Experiment) Rankdiff 2−1 (InWeb_IM) Rankdiff 2−1 (KEGG)
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Figure 4.6: The evaluation framework is robust to change in the source of the
known interaction network. The performance (y-axis) of the methods (x-axis) when
the interaction scores originated from i) experimental evidence available in STRING
(left column), ii) InWeb_IM (middle column), or iii) KEGG (right column).
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#Enriched pathways (KEGG) #Enriched pathways (REACTOME) #Enriched pathways (GO)




































































































































































Figure 4.7: The evaluation framework is robust to change in the source of the path-
way database. The performance (y-axis) of the methods (x-axis) when the pathway
database originated from i) KEGG (left column), ii) REACTOME (right column), or
iii) Gene Ontology (GO) (right column).
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developed by Li et al., 2016c, and iii) KEGG: Binary gene-gene interaction
annotated by KEGG (Kanehisa et al., 2016). Figure 4.6 show the corresponding
performances. We also tried alternative sources for the pathway database (D):
i) KEGG: gene sets derived from KEGG, ii) REACTOME: gene sets derived
from the Reactome pathway database (Fabregat et al., 2016), and iii) GO: gene
sets derived from gene ontology terms (Ashburner et al., 2000). Figure 4.7
show the corresponding performances.
Next, we compared the performances of SPICE and WGCNA – the current
top-performing method in greater detail. We noticed that SPICE consistently
performed better than WGCNA across almost all the tissues according to
interaction AUPR, Spearman ρ, and precision. We noticed the opposite trend
in terms of the number of enriched pathways. The relative performance of
SPICE tends to improve with an increase in the sample size.
Next, to determine whether SPICE improved performances because of
ranking computed using maximum spanning trees (MSTs) or because of mul-
tiple iterations, we ran SPICE excluding the ranking matrix R(t)2 computed
using maximum spanning trees. This approach is essentially equivalent to
running WGCNA for multiple iterations with subsamples and then aggre-
gating the results using rank-product. On average, this approach performed
equivalently to WGCNA and the standard SPICE performed better than this
































































































































































































































































































































































































































































































































































Figure 4.8: Comparison between SPICE and WGCNA. Improvement percentage
(y-axis) achieved by SPICE relative to WGCNA in each tissue (x-axis), categorized by
evaluation metrics (labels on the right). Improvement percentage has been clipped to
a maximum of 200%. Tissues are sorted by decreasing samples size from left to right.
Interaction: Interaction AUPR; Spearman: Spearman r; Precision; Hub: Hub AUPR;
Shared: Shared pathway AUPR; #Pathways: Number of enriched pathways; #eGenes:
Number of trans-eGenes; Rank:2-1: Rankdiff2−1; Rank:3-2: Rankdiff3−2.
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#Trans−eGenes (GTEx) Rankdiff (2−1)
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Figure 4.9: Ranking computed using maximum spanning trees improves perfor-
mances. This plot shows performances (y-axis) of the WGCNA, SPICE-C, and SPICE
(x-axis). SPICE-C refers to the approach where SPICE was run excluding the ranking
matrix R(t)2 computed using maximum spanning trees.
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Method Muscle–Skeletal Lung Pancreas
Brain–
Cerebellum
706 samples 515 samples 305 samples 209 samples
Random 10 sec (1) 5 sec (1) 5 sec (1) 5 sec (1)
CLR 21 sec (1) 18 sec (1) 12 sec (1) 10 sec (1)
WGCNA 32 sec (1) 38 sec (1) 25 sec (1) 22 sec (1)
ARACNE 5 min (1) 5 min (1) 4 min (1) 4 min (1)
PCor 18 min (1) 9 min (1) 9 min (1) 8 min (1)
MRNET 40 min (1) 19 min (1) 19 min (1) 19 min (1)
MRNETB 25 min (1) 25 min (1) 24 min (1) 24 min (1)
SPICE 31 min (1) 38 min (1) 35 min (1) 33 min (1)
GLasso 10.3 hr (1) 14.5 hr (1) 13.8 hr (1) 9.6 hr (1)
GENIE3 4.4 hr (6) 2.8 hr (6) 1.4 hr (6) 1 hr (6)
Table 4.1: Time ( and cores) used to reconstruct gene co-expression network of
5,000 genes in a representative set of tissues.
4.3.3 Run time
SPICE ran faster than GENIE3 or Graphical lasso, slower than WGCNA,
ARANCE, CLR, or Partial correlation, and comparable to MRNET or MER-
NETB. Here we report the time and the number of cores used to reconstruct
networks from a representative set of tissues.
4.4 Discussion
Here, we presented a novel co-expression network inference method, SPICE,
from gene expression profiles. SPICE uses maximum spanning trees to find
and prioritize potential direct interactions between genes. We also presented
eight metrics to evaluate co-expression networks using biological data. Evalu-
ation using biological data is more appropriate to assess biological networks
than that using simulated data. Because biology is generally more complex
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and noisier than simulation. However, evaluation by simulations is useful to
demonstrate that each method works when applied to a given data set with
certain properties.
We first evaluated SPICE using simulated data to demonstrate that our
method can capture relationships equivalently to the top-performing meth-
ods when applied to data generated from a multivariate normal distribution.
Then using biological data from 49 human tissues in GTEx, we demonstrated
that SPICE performs better than current popular methods in terms of four
important metrics: interaction AUPR, spearman ρ, precision, and shared path-
way AUPR. Relative to the current best-performing method WGCNA, SPICE
improves these four metrics by 8.3%, 56%, 19.3%, and 14.7%, respectively,
based on protein-protein interactions from STRING and hallmark gene sets
from MSigDB. It also performs equivalently to other methods in terms of hub
AUPR and rank difference.
SPICE performance is relatively low in terms of the total number of en-
riched pathways. This may happen because this metric uses absolute edge
weights, but SPICE computes edge rankings. Though SPICE assigns weights
based on a half-normal distribution, the weights merely represent rankings
without any statistical or physical meaning. SPICE’s low performance ac-
cording to weight-based metrics and improved performance according to
rank-based metrics together indicate that though SPICE may not be good at
assigning weights, it produces a good ranking.
Interestingly, partial correlation and graphical lasso performed better than
other methods in terms of the number of trans-eGenes. However, these two
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methods generally performed poorly according to the rest of the metrics.
SPICE performed equivalently to the other methods according to this metric.
Overall, SPICE and WGCNA performed the best and the second-best,
respectively, among all methods. The ranking remained roughly the same
when evaluated with alternative sources of ground truths, indicating the re-
liability of the evaluation framework. SPICE consistently performed better
than WGCNA for almost all tissues in terms of interaction AUPR, spearman ρ,
precision, and shared pathway AUPR, while the opposite happened in terms
of the number of enriched pathways. Notably, WGCNA achieved a high rank-
difference, Rankdi f f2−1, using both simulated and biological data. While a
high rank-difference using simulated data without any collinear genes is ex-
pected, it is somewhat surprising that WGCNA achieved as high Rankdi f f2−1
as SPICE using STRING with possible collinear genes. Next, when we looked
into per-tissue performances, we found that SPICE tends to improve with an
increase in the number of samples. As sequencing technologies are improving
rapidly and the cost of data collection is dropping, we think SPICE would be
even more effective in the future.
4.5 Code availability
Codes to infer networks using SPICE and compute evaluation metrics are
available as an R package on GitHub: https://github.com/alorchhota/spice.





In this final chapter, we first summarise the findings in this thesis, and then
discuss a few potential directions for future research.
5.1 Summary
In this thesis, we studied gene regulation in humans using two computational
approaches: co-expression network and trans-eQTLs. We bridged a few gaps
in current methods to detect regulatory patterns, applied current methods
with appropriate modeling to study biological processes, and developed novel
methods to discover gene regulatory relationships. The main contributions of
this thesis are summarized below.
• In Chapter 2, we discussed potential artifacts in trans-eQTL and co-
expression network studies arising from mapping errors due to sequence
similarity between genes. We found that trans-eQTLs from human RNA-
sequencing studies are strikingly affected by cross-mapping between
genes. Over 75% of trans-eQTLs detected using a standard pipeline
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were potentially false positives because of cross-mapping. The effect
was not as striking in co-expression studies as in trans-eQTLs, but we still
observed a higher than background fraction of cross-mappable genes
in top correlated gene pairs. We demonstrated that replication studies
cannot mitigate the concern of false positives, as cross-mapping is not
a random error, but a systematic error. We proposed a metric named
cross-mappability to quantify the potential for cross-mapping between
genes. We applied this metric to identify trans-eQTLs from diverse
human tissues using data from the Genotype-Tissue Expression (GTEx)
consortium.
• In Chapter 3, we studied the joint regulation of transcription and alterna-
tive splicing in humans. We presented a framework called Transcriptome-
wide network (TWN) to model both total gene expressions and relative
isoform levels into a single sparse network. Using data from GTEx, we
built and published transcriptome-wide networks for 16 human tissues.
We demonstrated that the total expression hubs with multiple isoform
neighbors in these networks are potential splicing regulators. We found
literature evidence for about half of the top 20 cross-tissue hubs, indicat-
ing the novelty of the rest. We also analyzed the tissue-specificity of the
regulatory relationships. Finally, we detected 20 genetic variants with a
distant regulatory impact on transcription and splicing.
• In Chapter 4, we presented a novel network inference method named
SPICE to study the regulation of transcription. SPICE uses maximum
spanning trees to prioritize potential direct regulatory relationships. We
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also formulated a comprehensive set of metrics to compare methods
using biological data. These metrics establish a standard to evaluate
biological networks. Using both simulated data and RNA-sequencing
data of 49 tissues in humans from GTEx, we benchmarked SPICE against
popular network inference methods. SPICE improves interaction iden-
tification on average by 8.3%, rank preservation by 56%, precision by
19.3%, and pathway sharing by 14.7% relative to the best currently avail-
able methods based on known protein-protein interactions from STRING
and hallmark gene sets from the molecular signature database (MSigDB).
Notably, SPICE improves relative performance with an increase in the
number of samples.
5.2 Future directions
5.2.1 Benchmarking the effects of unmeasured confounding
factor removal on network inference
Addressing batch effects and unmeasured confounding factors is challenging
for network inference from transcriptomic data. A common approach is
to regress out principal components (PCs) capturing non-random technical
confounding factors. However, some researchers remain skeptical that the
estimated PCs may contain biological signals and should not be regressed
out. Even if one decides to remove PCs, it is unclear how many PCs should
be regressed out. With the help of our suite of metrics to evaluate biological
networks presented in Chapter 4, we are now prepared to evaluate the effects
of removing PCs.
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5.2.2 Incorporating prior knowledge into SPICE.
SPICE uses gene expression profiles to infer a network. However, because of
the small number of samples relative to a large number of genes, SPICE may be
under-powered to robustly detect regulatory relationships. We may increase
the power by incorporating prior knowledge and transferring knowledge
from related tissue or cell types.
5.2.3 Network inference for cell-type-specific gene regulation
The field of sequencing technology is very vibrant and rapidly moving. Cur-
rent single-cell technology can perform sequencing from a single cell and
quantify a diverse range of features. Single-cell data, as opposed to bulk data,
allow us to study disease cells, rare cells (e.g., fetus, bone-marrow cells from a
cancer patient), and micro-organisms independently, and thus enable a wide
range of approachable questions. Understanding gene regulatory mechanisms
for each cell type would enhance our knowledge and thus improve our capac-
ity to control disease-causing genes. A challenge in current single-cell data is
that the quantification is generally incomplete leading to extensive sparsity.
Data is also noisy. Besides, multiple cells from the same individual do not
satisfy the common assumption of independent and identically distributed
(IID) random variables. By tackling these issues in a network inference model,
we can infer cell-type-specific gene regulatory networks. Transfer learning by
shared information between cell types could also improve network inference
for each cell type.
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5.2.4 Modeling genetic effects on pathways
Current eQTL studies commonly focus on the effects of a single genetic variant
on a single gene. However, in complex diseases, a pathway (set of genes),
rather than a single gene, is disrupted. Thus, pathway-regulating genetic vari-
ants might directly explain disease mechanisms. We may use dimensionality
reduction techniques to represent pathway activities using a small number
of features and find the genetic effect on these features. We can apply these
methods to currently known pathways. We can also apply this method to find
the genetic factors of the network modules susceptible to brain-diseases.
5.3 Concluding remarks
Overall, this thesis presented a range of computational methods to establish
best practices in co-expression network and trans-eQTL analysis. Outcomes
from these methods have the potential to explain biological processes and
thereby improve human health.
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GO BP id Biological process name Number of tissues
GO:0016070 RNA metabolic process 13
GO:0010467 gene expression 12
GO:0090304 nucleic acid metabolic process 12
GO:0044260 cellular macromolecule metabolic process 11
GO:0006396 RNA processing 9
GO:0006725 cellular aromatic compound metabolic pro-
cess
8
GO:0008380 RNA splicing 8
GO:0043170 macromolecule metabolic process 8
GO:0044237 cellular metabolic process 8
GO:0046483 heterocycle metabolic process 8
GO:0006139 nucleobase-containing compound metabolic
process
7
GO:0006807 nitrogen compound metabolic process 7
GO:0034645 cellular macromolecule biosynthetic process 7
GO:0044238 primary metabolic process 7
GO:0016071 mRNA metabolic process 6
GO:0034641 cellular nitrogen compound metabolic pro-
cess
6
GO:0071704 organic substance metabolic process 6
GO:1901360 organic cyclic compound metabolic process 6
GO:0006397 mRNA processing 5
GO:0032774 RNA biosynthetic process 5
GO:0051252 regulation of RNA metabolic process 5
GO:2000112 regulation of cellular macromolecule biosyn-
thetic process
5
Table A.1: Top GO biological processes among TE-IR hubs. We tested for enrich-
ment of all GO biological processes (BPs) in top 500 TE-IR hubs. We selected a BP
term in our analysis if that had at least 20 genes in our data. This table summarizes
the top BP terms based on the number of tissues they appear in top 20 strongest terms
(lowest p) in individual tissues.
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GO MF id Molecular function name Number of tissues
GO:0003723 RNA binding 15
GO:0044822 poly(A) RNA binding 15
GO:0003676 nucleic acid binding 14
GO:1901363 heterocyclic compound binding 14
GO:0003677 DNA binding 13
GO:0097159 organic cyclic compound binding 13
GO:0001071 nucleic acid binding transcription factor activ-
ity
9
GO:0003700 sequence-specific DNA binding transcription
factor activity
9
GO:0000975 regulatory region DNA binding 7
GO:0000989 transcription factor binding transcription fac-
tor activity
7
GO:0001067 regulatory region nucleic acid binding 7
GO:0008168 methyltransferase activity 7
GO:0044212 transcription regulatory region DNA binding 7
GO:0000981 sequence-specific DNA binding RNA poly-
merase II transcription factor activity
6
GO:0000988 protein binding transcription factor activity 6
GO:0003712 transcription cofactor activity 6
GO:0005488 binding 6
GO:0043565 sequence-specific DNA binding 5
GO:0043566 structure-specific DNA binding 5
GO:0003713 transcription coactivator activity 4
GO:0003714 transcription corepressor activity 4
GO:0016741 transferase activity, transferring one-carbon
groups
4
Table A.2: Top GO molecular functions among TE-IR hubs. We tested for enrich-
ment of all GO molecular functions (MFs) in top 500 TE-IR hubs. We selected a MF
term in our analysis if that had at least 20 genes in our data. This table summarizes
the top MF terms based on the number of tissues they appear in top 20 strongest
terms (lowest p) in individual tissues.
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Tissue TE–TE TE–IR IR-TE IR-IR
Adipose – Subcutaneous 62.50% 38.46% NA NA
Adipose – Visceral 53.85% 39.13% 100% 100%
Artery – Aorta 56.25% 38.46% 80% 100%
Artery – Tibial 53.85% 42.86% 100% 100%
Breast – Mammary 35.29% 55.17% 100% 100%
Cells – Transformed Fibroblasts 71.88% 55.26% 100% 100%
Esophagus – Mucosa 61.54% 62.50% 100% 100%
Esophagus – Muscularis 72.09% 20.00% 83.33% 85.71%
Heart – Left Ventricle 61.11% 79.49% 100% 100%
Lung 91.43% 30.00% 100% 100%
Muscle – Skeletal 69.70% 80.77% 100% 100%
Nerve – Tibial 69.57% 53.85% 100% 100%
Skin – Not Sun Exposed 70.00% 42.86% 100% 100%
Skin – Sun Exposed 41.67% 43.75% 100% 100%
Thyroid 75.00% 72.73% 100% 100%
Whole Blood 67.44% 79.31% 100% 100%
Table A.3: Differential expression in tissue-specific hubs. Here, we
consider a hub (rank ≤ 100) is tissue-specific if it is not present in top
500 hubs of any other tissues. This table shows the percentage of tissue-
specific hubs, categorized by hub type, with at least a 1.5 fold expression
level change between the tissue of interest and all other tissues. Here, NA
means there was no tissue-specific hub for corresponding category.
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Unique Differential
Tissue Expression Expression Other
Adipose – Subcutaneous 1.49% 66.58% 31.93%
Adipose – Visceral 2.99% 60.98% 36.04%
Artery – Aorta 4.22% 64.08% 31.71%
Artery – Tibial 1.98% 71.88% 26.14%
Breast – Mammary 4.24% 52.92% 42.85%
Cells – Transformed Fibroblasts 17.56% 70.97% 11.47%
Esophagus – Mucosa 6.65% 75.35% 18.01%
Esophagus – Muscularis 3.90% 61.98% 34.13%
Heart – Left Ventricle 14.58% 77.83% 7.59%
Lung 9.89% 61.62% 28.49%
Muscle – Skeletal 8.53% 83.08% 8.40%
Nerve – Tibial 4.13% 74.01% 21.86%
Skin – Not Sun Exposed 3.91% 70.86% 25.23%
Skin – Sun Exposed 2.45% 71.11% 26.44%
Thyroid 5.29% 77.29% 17.41%
Whole Blood 18.61% 77.41% 3.97%
Table A.4: Sources of tissue-specificity of edges. Unique Expression: Both
nodes connected by an edge were jointly included in TWN reconstruction
of the tissue of interest only i.e., at least one of the nodes were excluded
in every other tissue due to low expression or other filtering criteria.
Differential Expression: Both nodes connected by an edge were jointly
included in TWN reconstruction of multiple tissues and at least one of the
nodes was differentially expressed (at least 1.5 fold change in raw TPM)
between the tissue of interest and rest of the tissues. Other: Any other
source.
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Tissue Variant trans-eGene cis-eGene p-value FDR
Brain – Frontal Cortex rs11065155 COX5B TRIAP1 0.02 0.09
Brain – Anterior Cingulate Cortex rs470411 MAGOH TRIM29 3.36 × 10−3 0.02
Brain – Cerebellar Hemisphere rs66500423 UQCRQ NUMBL 2.36 × 10−2 0.15
Brain – Cerebellar Hemisphere rs66500423 UNC50 NUMBL 3.23 × 10−2 0.15
Brain – Putamen rs9371531 CHCHD1 RMND1 6.99 × 10−4 0.06
Thyroid rs934937 BRCA1 C15orf52 0.00299 0.09
Table A.5: Summary of tissue-specific trans-eQTLs from the cis-eQTL enrichment
tests in the TSNs. Columns include tissues, the RSID of the associated genetic variant,
the trans-eGene, the cis-eGene, the p-value of the trans-eQTL association, and the
FDR of this association.
148
Tissue Variant trans-eGene cis-eGene p-value FDR
Pituitary rs36077494 PTPRT KIRREL 4.66 × 10−3 0.16
Pancreas rs16913469 RNF38 DDIT4 4.61 × 10−4 0.15
Muscle – Skeletal rs11121453 SLC7A8 NPHP4 3.54 × 10−4 0.15
Brain – Substantia Nigra rs911110 UQCRQ PCNA 1.07 × 10−3 0.10
Brain – Hypothalamus rs116850387 LAMTOR2 TRIAP1 1.30 × 10−3 0.16
Brain – Hypothalamus rs73221368 DSCR3 TRIAP1 1.72 × 10−3 0.16
Brain – Hypothalamus rs73221368 LAMTOR2 TRIAP1 1.76 × 10−3 0.16
Brain – Hypothalamus rs73216931 ILK RILPL2 1.02 × 10−4 0.16
Brain – Hypothalamus rs9974252 TRIAP1 DSCR3 9.24 × 10−4 0.16
Brain – Hypothalamus rs28642307 RILPL2 BOLA1 1.42 × 10−3 0.16
Brain – Hypothalamus rs10742976 LAMTOR2 ILK 4.91 × 10−4 0.16
Brain – Hypothalamus rs960177 RILPL2 CALB2 9.55 × 10−4 0.16
Brain – Frontal Cortex rs2347443 MAGOH HSCB 1.33 × 10−4 0.13
Brain – Cortex rs45567235 TRIAP1 CCDC107 5.73 × 10−5 0.09
Table A.6: Tissue-specific trans-eQTLs from the 20 kb tests in the TSNs. Columns
include tissues, the RSID of the associated genetic variant, the trans-eGene, the
cis-eGene, the p-value of the trans-eQTL association, and the FDR of this associa-
tion. Only the most significant trans-eVariant per cis-eGene and trans-eGene pair is
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Figure A.1: Association of rs113305055 and rs59153288 with distal isoform ratio
across multiple tissues. We measured association for each variant with all isoform
ratios genome-wide, and plotted observed p-values against uniformly distributed ex-
pected p-values. Top four plots shows enrichment of rs113305055 in artery – tibial (A),
whole blood (B), skeletal muscle (C), and thyroid (D). Bottom four plots show enrichment
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